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ABSTRACT 
 
     The increasing production, use, and disposal of an expanding array of chemicals that enter the 
environment pose a serious threat to terrestrial and aquatic animals, as well as to humans. Fish in 
aquatic habitats are exposed to increasing concentrations of environmental contaminants, 
including environmental estrogens (EE). In this work, rainbow trout were used to assess the 
effects of EE on the growth hormone (GH)-insulin-like growth factor (IGF) system, specifically 
focusing on osmoregulation, organismal growth, and growth at the molecular level. Juvenile 
trout were exposed to varying concentrations of 17β-estradiol (E2), β-sitosterol (βS), and 4-n-
nonylphenol (NP) in vivo and in vitro. Real-time quantitative-PCR was used to measure levels of 
mRNA expression (GH receptor 1 (GHR1), GHR2, IGF-1, IGF-2, IGF receptor 1A (IGFR1A), 
and IGFR1B) in multiple tissues, including liver, gill, and muscle. Western blotting was used to 
elucidate signaling pathways affected by EE-treatment (e.g., JAK-STAT, MAPK, PI3K). 
Environmental estrogen-treated fish displayed depressed growth in terms of body mass and body 
length. The observed effects on organismal growth appeared to be due to a decrease in food 
conversion, as food consumption was not significantly different between treatment groups. 
Hepatic, gill, and muscle levels of mRNAs encoding GHR1, GHR2, IGF-1, IGF-2, IGFR1A, and 
IGFR1B decreased in a concentration-, time-, and compound-dependent manner in vivo and in 
vitro. Furthermore, EE-treated fish displayed decreased osmoregulatory function when subjected 
to a salt water challenge, as evaluated by measuring plasma chloride levels and mRNA 
expression of GHRs, IGFs, and IGFRs. The suppression of mRNA expression of components of 
the GH-IGF system by EE was linked to suppressed phosphorylation of JAK-STAT, MAPK, and 
PI3K-Akt in a concentration- and time-dependent manner in hepatocytes and gill filaments, an 
effect that was ER-dependent. Classically, the ER has been thought to function as a nuclear 
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receptor; however, the observed results support the notion that the ER (and thus EE) may have 
nongenomic effects as well. The results of this dissertation indicate that EE suppress growth at 
the organismal and molecular level via inhibition of growth-related signaling cascades and 
repression of gene expression elements of the GH-IGF system.  
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GENERAL INTRODUCTION 
     The increasing production, use, and disposal of an expanding array of chemicals that enter the 
environment pose a serious threat to terrestrial and aquatic animals, as well as to humans. Fish in 
aquatic habitats are exposed to increasing concentrations of environmental contaminants, 
including endocrine disrupting compounds (EDCs). EDCs are introduced to the environment via 
the air, water, and soil, and once present, may persist at low levels. Chronic exposure to these 
compounds may cause a host of detrimental effects. While much of the research to date has 
focused on the effects of EDCs on the reproductive system, less is known about how these 
compounds affect growth. In this work, rainbow trout were used to assess the effects of EDCs, 
specifically environmental estrogens (EE), on the growth hormone (GH)-insulin-like growth 
factor (IGF) system. Our specific aim was to elucidate the effects of EE on osmoregulation, 
organismal growth, growth at the molecular level both in vitro and in vivo, and the signaling 
pathways responsible for the observed effects on growth.  
 Endocrine Disruption 
Endocrine Disrupting Compounds 
     Rapid technological development over the last 60+ years has been accompanied by increased 
production, use, and disposal of an expanding array of chemicals. As a result, chemicals are 
introduced into the environment through the air, soil, and water. Increasing research shows the 
deleterious effects of environmental contamination on microbes, aquatic and terrestrial plants, 
invertebrates, fish, amphibians, birds, and mammals, including humans (Hester and Harrison, 
1999; Diamani-Kandarakis et al., 2009), primarily due to the ability of these compounds to 
bioaccumulate in tissues. Alarming to the universal health of organisms is the notorious ability of 
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these compounds to affect the endocrine system, thus leading to the popular term endocrine 
disrupting compounds (EDCs). 
     Endocrine disruptors are defined by the Environmental Protection Agency as exogenous 
chemical substances or mixtures that cause adverse effects to an organism, its progeny, 
populations, or subpopulations through altering the structure or function of the endocrine system. 
Endocrine disrupting compounds can act through a variety of mechanisms, including direct 
interaction with hormone receptors (i.e., agonistic or antagonistic). Endocrine disrupting 
compounds also can indirectly interfere with the endocrine system by affecting the concentration 
of hormones (i.e., hormone metabolism, hormone synthesis, storage, and release) and the 
concentration of hormone receptors. As a result of interfering with the endocrine system, these 
compounds can subsequently affect a number of physiological processes including development, 
osmoregulation, male and female reproduction, neuroendocrinology, obesity, growth, and 
disease states such as breast and prostate cancer (Diamani-Kandarakis et al., 2009). A wide range 
of EDCs can be found in the environment, which has led to great concern about how these 
compounds affect wildlife and human health alike. 
     There are several classes of EDCs, including pesticides, industrial chemicals, plastics, fuels 
and natural hormones (reviewed in Lintelmann et al., 2003; Diamani-Kandarakis et al., 2009). 
EDCs enter soil and water through agricultural (including farm animal production) and 
veterinary (e.g., diethylstilbestrol, estradiol cypionte; widely used in dogs, cats, and horses) 
application, manufacturing, natural hydrological processes, and watershed/waste water 
management practices. Of particular concern is a broad spectrum of natural and synthetic 
compounds that mimic estrogen. Environmental estrogens (EE) include endogenous and 
synthetic animal estrogens (e.g., 17β-estradiol), phytoestrogens (β-sitosterol), mycotoxins (e.g., 
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zearalenone), organochlorine pesticides (e.g., DDT), polychlorinated biphenyls (PCBs), and 
alkylphenol polyethoxylates (APEs; e.g., 4-nonylphenol) (Turner, 1999; Birkett, 2010).  
     Once in the environment, these compounds can persist at low levels (resistant to chemical, 
biological, and photolytic degradation), thus disrupting aquatic and terrestrial habitats at multiple 
levels. For example, some organic pesticides, such as DDT, DDE, and methoxychlor, are 
particularly persistent and can be found in areas where they have never been used or produced, 
such as the Arctic (Vallack et al., 1998). Aquatic organisms have been shown to act as valuable 
biological indicators of EDC exposure and studies on the effects of these compounds on teleosts 
have proven to be invaluable in studying the effects of EDCs on terrestrial vertebrates, including 
humans. 
     Endogenous and synthetic estrogens have been detected in the effluent of publicly owned 
sewage treatment plants and surface waters on every continent (Anderson et al., 2012). In the 
environment the concentrations of several contaminants have been well-documented and appear 
to contrast greatly depending largely upon location. For example, β-sitosterol is a highly 
lipophilic compound found in plant oils, legumes, and wood that has been found in effluent from 
paper mills at significant concentrations. Cook et al. (1996) found that total sterol concentrations 
in effluent from pulp and paper mills in the U.S. ranged from 71 to 535 µg/l, while Fernandez et 
al. (2007) found that levels reached only 7.2 μg/L in a Canadian testing site. A breakdown 
product of the APEs (industrial chemicals), 4-n-nonylphenol (NP), common in a variety of 
products including detergents, commercial and household cleaning products, and plastics 
(Nimrod and Benson, 1996, Thiele et al., 1997), has been measured in lakes and rivers around 
the world. In rivers in England, concentrations of alkylphenols have reached levels up to 336 
µg/l (Blackburn and Wadlock, 1995). Conversely, APE concentrations were shown to vary 
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between 3 to 11.5 μg/L depending on seasonal temperature in a river in the United States 
(Lozano et al., 2012). In Europe, models have predicted that sewage discharge concentrations of 
ethinylestradiol are higher than the proposed environmental quality standard (0.035 ng/L) for up 
to a third of the total lengths of the rivers (Johnson et al., 2013), while in Canada ethinylestradiol 
wasn’t detected at measurable levels in wastewater effluent (Metcalfe et al., 2013). While much 
of the contamination has been localized to streams and rivers, Scott et al. (2006) hypothesized 
that even aquatic vertebrates in the open ocean may be experiencing similar endocrine disrupting 
effects as vertebrates exposed via more direct routes due to effects on the food chain. Despite the 
fact that many EE are found at levels below the legal limit, the potential long-term impact of 
chronic exposure to low levels is not clear, especially given the persistence of the compounds, 
the ability to be rapidly transferred through the food web and accumulate in tissues, and the 
capacity to elicit epigenetic effects that may affect progeny (Lech et al., 1996; Phillips and 
Harrison, 1999; Uguz et al., 2003; Diamani-Kandarakis et al., 2009).  
     The detrimental effects of EDCs can be observed at the organismal and molecular level and 
include developmental and reproductive effects (e.g., sex reversal, sterility, altered reproductive 
timing and behavior) that result in reduced fecundity in teleosts and mammals (Kime et al., 1998; 
Cabaton et al., 2011). The reproductive effects of EDCs have been particularly well-studied in 
vertebrates (reviewed in Dickerson and Gore, 2007 and Kloas et al., 2008). For example, NP (at 
low concentrations) has been shown to inhibit testicular growth in rainbow trout (Jobling et al., 
1996), while phytosterols have been linked to reproductive dysfunction in both rainbow trout and 
goldfish (MacLatchy and Van der Kraak, 1995; Tremblay and Van der Kraak, 1998). Similarly, 
in mice long-term EDC exposure (specifically BPA) lead to uterine abnormalities including 
adenomyosis, leiomyomas, stromal polyps, and hyperplasia (Newbold et al., 2007). 
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     In addition to reproductive effects, a host of other disease states/physiological disruptions 
may arise following EDC exposure. Diethylstilbestrol (DES) has been implicated as both an 
estrogen mimetic and as a carcinogen. Exposure of neonatal mice to DES has been shown to 
promote the development of uterine carcinomas, presumably via epigenetic mechanisms (i.e., 
alteration of chromatin modifying proteins) (Newbold et al., 1990; Jefferson et al., 2013). 
Furthermore, EDCs have been observed to alter behavior (Filby et al., 2012; Wolstenholme et 
al., 2012; Brodin et al., 2013). For example, altered behavior (i.e., more active fish, less social 
fish, and bolder fish) has been observed in European perch following exposure to 
benzodiazepines, a group of persistent psychotherapeutic drugs (Brodin et al., 2013).  Other 
endpoints of EDC exposure (e.g., metabolism and osmoregulation) will be further discussed 
later.  
Growth Effects of EDCs 
     While several studies have focused on the reproductive aspects of endocrine disruption, fewer 
studies have focused on how these compounds affect growth. In order to understand the effects 
that EDCs have on growth, it is important to understand the major hormonal mechanisms 
regulating growth in vertebrates. Organismal growth integrates a host of biological processes that 
lead to a fertilized egg developing into an adult and to the maintenance and modulation of adult 
structures appropriate to their function. Animal growth is influenced by genetic, environmental, 
and nutritional factors. Extrinsic factors are particularly important in the growth of 
poikilothermic vertebrates such as teleost fish, which rely on temperature, photoperiod, and food 
availability to trigger developmental processes such as hatching, metamorphosis, smoltification, 
sexual maturation, and spawning (Bjornsson, 1997; Duan, 1998; Mommsen, 2001). Integration 
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of external and internal cues leads to the coordination of animal growth via the interplay of 
numerous hormones (Very and Sheridan, 2004). 
Organismal Growth 
     A primary growth promoting factor in vertebrates is growth hormone (GH), which has been 
isolated from the pituitary gland from representatives in every extant class of vertebrate (Harvey, 
1993). GH results in increased amino acid uptake, increased RNA synthesis, increased protein 
synthesis, increased muscle growth, and increased cartilage synthesis (Tannenbaum and 
Epelbaum, 1999; Butler and LeRoith, 2001). GH is produced primarily in the brain, gill, and 
heart, and to some extent in ovary, kidney, liver, and pyloric caeca in rainbow trout (Yang et al., 
1999). GH elicits its physiological effects by binding to GHRs, members of the class I cytokine 
receptor family. In rainbow trout there are two receptor isoforms, GHR1 and GHR2 (Agellon et 
al., 1988; Reindl and Sheridan, 2012). These two receptors are differentially expressed and found 
in the liver (primary location), muscle, adipose tissue, mammary gland, bone, kidney, and other 
tissues (Kopchick and Andry, 2000). Like most components of the GH-IGF system, expression 
of GHRs is regulated by development, hormone availability, and nutritional status. Growth 
hormone binding protein (GHBP) is a protein typically found in serum and membranes in both 
mammals and teleosts and is responsible for regulating the availability of GH in the organism 
(Baumann et al., 1988). In rats and mice, it appears that GHBP and GHR are products of the 
differential splicing of a single gene (Talamantes and Ortiz, 2002), whereas in humans, GHBPs 
appear to be produced via proteolytic cleaving of the membrane-bound GHR (Forsyth and 
Wallis, 2002). 
     Many of the growth-promoting actions of GH in fish and other animals are mediated by 
insulin-like growth factor-1 (IGF-1) (Moriyama et al., 2000; LeRoith et al., 2001; Mommsen, 
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2001; Reindl and Sheridan, 2012). Following stimulation of the release of GH by the pituitary, 
circulating GH binds to its cytokine receptor and subsequently activates signaling pathways such 
as JAK-STAT, which leads to the synthesis and secretion of IGF-1 from liver and other sites 
(e.g., gill, muscle, etc.). IGF-1, in turn, binds to IGF-1 receptors (IGFRs), which are encoded by 
two different genes in rainbow trout (Greene and Chen, 1999; Reindl and Sheridan, 2012). These 
receptors are expressed in teleost brain, ovary, gill, muscle, and heart (Duan, 1998; Greene and 
Chen, 1999). Following binding to IGFRs on target tissues, pathways such as MAPK and 
PI3K/Akt are activated, ultimately resulting in the growth promoting and other biological actions 
(e.g., energy metabolism, osmoregulation) of IGF-1 (Fig. 1) (Kelley et al., 2000; Butler and 
LeRoith, 2001; Wood et al., 2005). Subsequently, IGF-1 inhibits the synthesis and secretion of 
GH via a negative feedback mechanism. The availability and actions of IGF-1 are influenced by 
IGF-1 binding proteins (IGFBPs) (Duan, 2002; Duan and Xu, 2005; Wood et al., 2005). IGFBPs 
also have direct, IGF-1-independent effects on growth (Butler and LeRoith, 2001; Duan and Xu, 
2005; Wood et al., 2005). Additionally, IGF-1 may have growth-modulating effects that are 
independent of GH (Duan and Xu, 2005). While imperative for growth, the GH-IGF system has 
also been shown to play an important role in other physiological processes including energy 
metabolism, reproduction, and osmoregulation. 
     Much of the research on the regulation of animal growth has focused on the production and 
release of GH from the pituitary (Harvey, 1993). In most species studied, including mammals 
and fish, pituitary GH release is under dual antagonistic control from the hypothalamus as well 
as from systemic hormones. The hypothalamic hormone growth hormone-releasing hormone 
(GHRH) acts to promote GH transcription (Kopchick and Andry, 2000). In teleosts, hormones 
such as ghrelin, E2, and dopamine have been shown to lead to increased plasma GH levels (Zou 
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et al., 1997). Major inhibitors of GH release are somatostatins, a structurally and functionally 
diverse family of peptides derived from multiple genes with wide-spread anatomical distribution 
(Nelson and Sheridan, 2005; Klein and Sheridan, 2008). Dopamine, GHRH, gonadotropin 
releasing hormone (GnRH), thyrotropin releasing hormone (TRH), cholecystokinin (CCK), and 
ghrelin, on the other hand, stimulate GH release (Canosa et al., 2007). Given the possibility of 
both a direct and indirect mode of action of GH and the complexity of the GH-IGF-1 system, 
which in teleost fish, such as rainbow trout, includes multiple subtypes of GHRs and IGFRs, it is 
becoming increasingly clear that the regulation of growth may occur at many levels outside the 
pituitary (Talamantes and Ortiz, 2000; Bjornsson et al., 2004; Reinecke et al., 2005; Klein and 
Sheridan, 2008).  
     While the endogenous endocrine regulation of growth appears to be fairly well-understood, 
studies have just begun to emerge over the past few years indicating how exogenous compounds 
such as EDCs may alter the GH-IGF system (Fig. 1). As growth is a multifaceted process, it is 
important to examine the effects of EDCs not only from the viewpoint of level of growth 
regulation (e.g., GH sensitivity, IGF-1 synthesis), but also from the aspect of organismal life 
history. Fish are an interesting species to study because they display indeterminate growth, and 
thus are continuously allocating energy resources towards growth. From a life history 
perspective, juveniles typically allocate energy resources towards growth prior to undergoing 
sexual maturation. Treatment at this critical life stage with a sex steroid such as estrogen, or a 
compound mimicking estrogen (e.g., β-sitosterol, NP), may reprogram the fish to divert energy 
resources towards reproduction rather than growth. Additionally, the effects of exposure of an 
organism to an EDC may not be manifested until later in life, thus adding another degree of 
complexity to the physiological effects of these compounds. Evidence of alterations to the GH- 
9 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic representation of the growth hormone-insulin-like growth factor system in 
vertebrates and possible targets of endocrine disrupting compounds on this axis. growth 
hormone, GH; growth hormone binding protein, GHBP; growth hormone receptor, GHR; 
insulin-like growth factor, IGF; insulin-like growth factor binding protein; insulin-like growth 
factor receptor, IGFBP; endocrine disrupting compounds, EDCs 
 
 
 
 
 
 
 
 
 
 
 
 
 
10 
 
 
 
 Pituitary 
IGFR1A/1B 
Target 
Tissues 
 
GHBP 
IGFBP 
EDCs 
Brain  
GH 
Liver  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IGF-1/2 
GHR1/2 
? 
? 
? 
? 
? 
11 
 
 
IGF system at these different levels and different life history stages (larval, juvenile, etc.) is 
subsequently presented. 
     EDCs have been observed to target growth at multiple levels, including overall organismal 
growth in several teleost species. At the embryonic/larval stage, BPA, NP, malathion, and 
perfluorinated chemicals have been shown to depress growth in terms of body weight and body 
length in medaka, Atlantic salmon, zebrafish (Cook et al., 2005; Lee et al., 2012; Spachmo and 
Arukwe, 2012). Zebrafish, stickleback, fathead minnow, and tilapia exposed to ethinylestradiol 
at multiple stages of life (e.g., larval, fry, juvenile) also exhibited retarded growth (Bell, 2004; 
Schafers et al., 2007; Johns et al., 2011; Shved et al., 2008). Comparable results have been 
observed in other juvenile teleosts where aqueous exposure of rainbow trout, Atlantic salmon, 
Arctic charr, swordtails, and platyfish to NP, methoxychlor, Arochlor, or PCBs has been shown 
to reduce organismal growth when compared to control fish (Magliulo et al., 2002; Arsenault et 
al., 2004; Jorgensen et al., 2004). Similarly, sublethal exposure to the pesticides malathion and 
dimethoate was shown to decrease final body weight and standard growth rate in juvenile Nile 
tilapia (Sweilum, 2006). Acute aqueous exposure of juvenile black-striped pipefish to 
ethinylestradiol caused diminished juvenile growth, whereas exposure to the androgenic 
compound, tributyltin (TBT) lead to an increase in growth. Interestingly, when the juveniles 
were exposed to a mixture of ethinylestradiol and TBT, growth was depressed, thus suggesting a 
more potent effect of ethinylestradiol on juvenile growth (Sarria et al., 2011). Conversely, 
cadmium exposure in juvenile tilapia (O. mossambicus) increased growth in length and weight 
and caused early maturation in tilapia fries (Amutha and Subramanian, 2013). While many 
studies have focused on aqueous exposure, dietary exposure of yellow perch to E2 also lead to an 
increase in length and weight of juveniles compared to control animals (Goetz et al., 2009).  
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     While the period of development may be a critical window of exposure, adult fish are not 
immune to the effects of EDCs. BPA has been shown to retard growth in adult rainbow trout 
(Jobling, 1993; Warhurst, 1994). Adult zebrafish and fathead minnow exposed to ethinylestradiol 
at also exhibited retarded growth (Bell, 2004; Schafers et al., 2007). Dietary exposure to DES 
caused diminished growth rates in European catfish, whereas no effects on growth were observed 
with dietary exposure to E2 (Krol et al., 2013). While growth in adult zebrafish were subjected to 
endosulfan treatment was not affected after a 21 d exposure, the HSI of male fish was elevated 
(Han et al., 2011), possibly indicating the diversion of energy resources towards reproduction. 
Taken together, these studies indicate that EDCs of numerous classes are capable of eliciting 
growth-disrupting effects in an organism at distinct life stages, with the most critical period 
appearing to occur before sexual maturity. The differential effects of EE on organismal growth 
could be partially attributed to the exposure of teleosts during the juvenile life stage, a stage in 
which the fish are typically undergoing rapid growth (Mommsen, 2001). 
     Many of these studies examined the effects of EDC exposure on growth following continuous 
exposure; however, chronic exposure of fish to low levels of many EE may cause deleterious 
growth effects for an extended period of time post-exposure. For example, Ashfield et al. (1998) 
found that APEs can cause a decrease in body weight and length up to one year following a one 
month exposure in female rainbow trout. Similarly, Nye et al. (2007) exposed female killifish to 
contaminated soil (high in several types of pollutants) and then switched these fish back to a 
reference site (low in pollutants) and discovered that offspring born to these females were 
smaller and had lower growth rates than the groups that remained in a constant environment. The 
authors (Nye et al., 2007) suggested that these results may be due to a fitness tradeoff that occurs 
due to contaminant resistance. The aforementioned studies support the notion that both the age of 
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the organism, as well as the duration of the exposure, may have immediate and lasting effects on 
growth.   
     Endocrine disrupting compounds have been shown to be able to regulate growth at the level 
of the pituitary in many teleost species, as well as regulate growth via extrapituitary effects on 
the growth axis. The perfluorinated chemical, PFOS, was found to produce a time-dependent 
decrease in GH expression in both the head and body region of Atlantic salmon larvae and 
embryos (Spachmo and Arukwe, 2012). Similarly, pituitary GH mRNA expression in tilapia was 
suppressed in both females (75 days post fertilization) and males (165 days post fertilization) 
following dietary exposure to ethinylestradiol (Shved et al., 2007).  
     Studies on peripheral organs in teleosts have demonstrated negative effects on growth 
hormone sensitivity as well. Treatment with E2 or ethinylestradiol has been shown to lead to 
decreased hepatic GHR mRNA expression in Atlantic salmon, tilapia, sea bream, rainbow trout, 
and fathead minnow (McCormick et al., 2005; Davis et al., 2007; Filby et al., 2007; Davis et al., 
2008; Jiao and Chang, 2010; Norbeck et al., 2011). In agreement with the GH mRNA expression 
data, synthesis of GH was also suppressed in several studies. For example, circulating levels of 
GH were significantly depressed in catfish and Arctic char exposed to malathion and Arochlor, 
respectively (Jorgensen et al., 2004; Lal et al., 2013). This suppression of GH appeared to be in 
part due to the down-regulation of GHR expression, as was found in seabream hepatocytes 
exposed to BPA in vitro (Jiao and Chang, 2010). Moreover, functional expression of GHRs was 
diminished following aqueous exposure of Atlantic salmon to E2 and NP in an osmoregulatory 
context (Lerner et al., 2012).  
     A number of studies have observed a depression in GH or GHR mRNA levels, but other 
studies have yielded conflicting results at the level of both the pituitary and peripheral organs. 
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For example, Yatedie and Male (2002) found no difference in pituitary GH mRNA expression 
following exposure of Atlantic salmon to E2 or NP. Similarly, Filby et al. (2006) exposed 
fathead minnows to ethinylestradiol for 14 days and observed no change in either liver or brain 
GH expression, whereas gonadal GH mRNA expression was up-regulated. Pituitary GH 
secretion in goldfish was significantly increased in E2-treated fish, however GH mRNA levels 
remained unchanged (Zou et al., 1997). Conversely, in cultured rainbow trout pituitary cells, 
TCDD, DDT, or E2 increased GH mRNA levels (Elango et al., 2006). This is in agreement with 
a study by Holloway and Leatherland (1997) that found that GH plasma levels increased in 
juvenile rainbow trout following E2 administration. Interestingly, the differences in GH and 
GHR mRNA and protein expression in these studies do not appear to be age-dependent, thus it is 
possible that differences in GH sensitivity, synthesis, etc., expression are due to treatment with 
different EDCs (e.g., physical and chemical nature of EDC), different EDC treatment 
concentrations or routes of administration (aqueous versus injected versus in vitro in above 
studies), different exposure time (24 hours to 21 days), species-specific differences (e.g., 
different isoforms of GHRs, tissue-specific distribution of GHRs), or overall health of the 
organism (i.e., ability to metabolize EDCs).  
     While many studies have examined the direct effects of EDCs on GH, some studies have also 
examined the possibility of indirect effects on this axis. Somatostatin is well-known as a growth 
inhibitor in rainbow trout (Very et al., 2005). Insulin and GH stimulate SSTR expression in 
rainbow trout, suggesting that regulation of SSTRs may be important for the coordination of 
growth, development, and metabolism of vertebrates (Nelson et al., 2006). Canosa et al. (2002) 
demonstrated that E2 increased expression of somatostatin (SS) in goldfish brain. Similarly, BPA 
can modulate the level of SS in the diencephalic region of the brain in Mediterranean rainbow 
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wrasse (Alo et al., 2005). In both cases, E2 or E2 mimetics may indirectly suppress hypothalamic 
GH synthesis.  
     Examining further levels of the GH-IGF system such as IGF synthesis has shown to be 
equally challenging. The majority of the studies looking at IGF expression following EDC 
exposure have looked at the effects of EDCs, particularly estrogen mimetics, at the level of the 
liver and target tissues (e.g., gill, ovaries, etc.). For example, dietary ethinylestradiol treatment 
was observed to down-regulate hepatic IGF-1mRNA expression in developing tilapia in vivo 
(Shved et al., 2007). Similar decreases were observed in sexually mature sea bream (Carnevali et 
al., 2005), tilapia (Riley et al., 2004), fathead minnow (Filby et al., 2006), and rainbow trout 
(Norbeck et al., 2011) exposed to E2 (in vitro and in vivo) and sexually mature sea bream 
exposed to BPA (Jaio and Chang, 2010). In Atlantic salmon larvae and embryos, PFOS was 
found to produce a decrease in IGF-1 expression (Spachmo and Arukwe, 2012). The routes of 
administration for these studies included dietary, aqueous, intraperitoneal, and cell culture. In 
agreement with observed effects on mRNA expression levels, developing tilapia treated with E2 
or ethinylestradiol had reduced serum IGF-1 levels up to a month post-exposure (Shved et al., 
2007; Davis et al., 2007; Davis et al., 2008). Similarly, aqueous exposure of Atlantic salmon to 
NP also lead to a decrease in plasma IGF-1 levels after an extended period of time (Arsenault et 
al., 2004; McCormick et al., 2005). Malathion and Arochlor suppressed IGF-1 serum levels in 
catfish (Lal et al., 2013) and Arctic charr (Jorgensen et al., 2004), respectively. 
     In contrast to the previous studies, juvenile perch fed E2 demonstrated an increase in hepatic 
IGF-1 (Goetz et al., 2009). Similarly, IGF-1 mRNA expression was induced in the brain and 
pituitary of males and female fathead minnows following exposure to ethinylestradiol (Filby et 
al., 2006). However, target tissues such as gill and liver showed depressed IGF-1 mRNA levels 
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(Filby et al., 2006; Filby et al., 2007), which was in agreement with the above studies. As 
previously mentioned, these contradictory results may arise from differences in length of 
exposure, health of the organism, type of exposure, or concentration of EDC. From a 
toxicological standpoint, concentration effects are often inconsistent, as EE may have 
unpredictable effects at low doses which are not anticipated based on the effects observed at 
higher doses (Vandenberg et al., 2012). The variation in growth effects of EE has been difficult 
to generalize and no clear patterns between studies have emerged to date. 
     While less is known about the effects of EDCs on IGF sensitivity, a decrease in IGFR mRNA 
was observed in target tissues (e.g., gill, red and white muscle, etc.) of sexually maturing fathead 
minnow treated with E2 (Filby et al., 2006), and a functional decrease in expression of IGFRs 
was observed in juvenile rainbow trout exposed to E2 (Norbeck et al., 2011). Conversely, 
aqueous exposure of salmon larvae to PFOA displayed fluctuating IGFR mRNA expression 
levels across the time course in body tissue, while PFOS treatment was associated with increased 
levels of IGFRs in the head region (Spachmo and Arukwe, 2012). In this case, contradictory 
results may correspond to the age of the organism as IGFRs play a vital role in transducing the 
developmental signals of IGF-2 in many vertebrates. 
     As EE affect central elements of the GH-IGF system, it is not surprising that E2 has been 
associated with alterations in GHBP and IGFBP in teleosts and mammals. E2 has been linked to 
changes in plasma levels of GHBP. Co-treatment of mouse hepatocytes with GH and E2 
increased expression of GHBP (Contreras and Talamantes, 1999) and increased plasma levels of 
GHBP in rats (Carmignac et al., 1993). Similarly, E2 has been shown to stimulate the release of 
IGFBP (25 kDa and 30 kDa) from hepatocytes in tilapia in a sex-dependent manner (Riley et al., 
2004). In humans, E2 has also been observed to increase circulating levels of IGFBP (Paassilta et 
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al., 2000). It is plausible that EE may alter GHBP and IGFBP expression, and thus the 
bioavailability of GH and IGF. Taken together, these data support the possibility that EE may in 
part elicit their negative effects on the GH-IGF system through interactions with the binding 
proteins. 
     Some of the observed effects of EDCs on growth are particularly alarming due to recent 
evidence that the epigenetic effects of EDCs are heritable across multiple generations, thus 
potentially leading to a host of diseases states (Anway et al., 2005; Anway and Skinner, 2006). A 
classic example of epigenetic modification by an EDC is that of DES offspring. Pregnant women 
who took DES were observed to have an abnormally high rate of reproductive tract anomalies 
and rare cervical cancers. These effects appear to be transmitted to subsequent generations via 
modifications to DNA methylation patterns (Li et al., 1997; Skinner et al., 2005). In addition to 
DES, a host of EDCs including phthalates, BPA, DDT, vinclozolin, and methoxychlor have also 
been observed to be capable of epigenetic modifications (e.g., histone modifications, DNA 
methylation, DNA acetylation, etc.) (Anway et al., 2005; Dolinoy et al., 2007; Kang and Lee, 
2005; Nilsson et al., 2008; Shutoh et al., 2009).  
     Although the epigenetic effects of EDCs in regards to growth are not well known, there have 
been studies showing that exposure of oocytes to BPA prior to fertilization leads to retarded 
growth in the adult trout (Aluru et al., 2010). Additionally, the results of this study found that 
embryonic GH levels and GHR transcript levels were altered, IGF mRNA and IGFR mRNA 
expression levels were suppressed in embryogenesis, and plasma glucose and plasma cortisol 
levels were subsequently altered in the adult trout (Aluru et al., 2010). In mammals, further 
evidence of epigenetic modification to somatotropic genes was observed in a study by Ren et al. 
(2001) in which the IGFR gene appeared to be modified by the phytoestrogen daidzein in piglets. 
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These epigenetic effects may also be indirectly related to effects of EDCs on IGF levels, as IGF-
1 has been shown to promote the acetylation of histone H3 and H4 (Sun and D’Ercole, 2006) and 
regulate methionine synthase (thus regulating the availability of methyl donors) (Waly et al., 
2004). While these studies were completed in neural tissue (i.e., cortex, hippocampus, 
neuroblastoma cell line), the ability of IGF-1 to promote both acetylation and methylation of the 
genome, and therefore affect expression of the functional IGF-1 protein, may indicate that 
similar effects in other tissues, specifically those known to play an integral role in growth (e.g., 
liver), are possible.  
     There is a delicate balance that exists between the gonadotropic and somatotropic axis when 
an organism is growing and developing. Generally, hepatic pathways play an important role in 
regulating the balance between allocating energy towards gonadal versus somatic growth. For 
example, in several fish species, energy may be diverted from somatic growth to development as 
evidenced by increased vitellogenin (an egg yolk precursor protein generally only produced by 
female fish in teleosts) synthesis following exposure to environmental estrogens (Pelissero et al., 
1993; Mellanen et al., 1996; Tremblay and Van der Kraak, 1998; Kime et al., 1999; Bowman et 
al., 2002; Kidd et al., 2007). The differential effects of EDCs on somatotropic genes appear to 
depend on a host of variables. As the action of GH in the liver is ultimately mediated by IGF-1, it 
is reasonable to suggest that GH insufficiency (in terms of reduced GH sensitivity in target 
organs) and IGF insufficiency (in terms of reduced IGF production/release and reduced IGF 
sensitivity in target organs) underlies, at least in part, the actions of EDCs, which are not only 
acting at numerous levels in the GH-IGF system in teleosts, but also are triggering downstream 
effects in the peripheral organs to decrease the growth-promoting actions of GH. 
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Other Vertebrates 
     While teleosts make an excellent model organism for examining the detrimental effects of 
EDCs, several studies have used other systems and found comparable results, likely due to the 
highly conserved nature of the GH-IGF axis among vertebrates. In terms of overall organismal 
growth, exposure of guppies to the phthalate, DEHP (di-ethyl-hexyl-phthalate) was associated 
with a decrease in both weight and length compared to the control counterparts (Zanotelli et al., 
2009). Following aqueous exposure to coal combustion waste, green frog tadpole and wood frog 
tadpole growth was not only delayed, but treatment groups were significantly smaller than the 
control tadpoles at metamorphosis (Snodgrass et al., 2004). 
     Examining the GH-IGF system at the molecular level in other vertebrates exhibited variable 
results. Cows fed daidzein had offspring with an increased birth weight and up-regulated IGFR 
mRNA levels in muscle tissue (Ren et al., 2001). Chicken eggs injected with Arochlor showed 
increased levels of GH mRNA in the pituitary, whereas no effect was observed on plasma GH 
and IGF (Gould et al., 1997). In combination, GH and E2 increased GHR mRNA levels in mouse 
hepatocytes, while no effects were observed with either singular treatment, thus suggesting the 
two hormones act synergistically to elicit the observed physiological effects (Contreras and 
Talamantes, 1999). Conversely, BPA has been shown to be able to suppress GHRH-stimulated 
and basal levels of GH (Katoh et al., 2004). This suppression of GH appears to be in part due to 
the down-regulation of GHR expression, as was found in seabream hepatocytes (Jiao and Cheng, 
2010) and ovine pituitary cells (Katoh et al., 2004) exposed to BPA. Dietary exposure to the 
phytoestrogen genistein was observed to reduce IGF levels in a dose-dependent manner in 
transgenic mice (Lamarthiniere et al., 2002). In vivo and in vitro studies with DDT and its 
derivatives have shown that DDE can increase the expression of IGF in rats and humans 
20 
 
 
(Holloway et al., 2007). In addition, DDE may to be linked to diminished IGF-1 levels in boys 
(Zumbado et al., 2010). As was the case in teleosts, these effects were highly variable and could 
depend on a number of factors including the sex and age of the organism, the mechanisms 
responsible for growth control in a particular organism, the route of exposure to the EDC, and 
the compound and tissue examined. 
     Indirect growth effects, such as those observed in EDC-exposed progeny have been 
documented as well. Female rats given octylphenol produced offspring with significantly 
suppressed growth compared to control rats (Sharpe et al., 1995). Similarly, in humans, PCB and 
dioxin concentrations in pregnant women’s bodies were observed to be negatively correlated to 
the birth weight of the offspring (Fein et al., 1984). Maternal exposure of ducks to daidzein led to 
a significant decrease in the mass of ducklings at hatching. At the molecular level, reduced GH 
mRNA expression in the pituitary, and decreased IGF1R mRNA expression in the liver was 
observed in the ducklings (Zhao et al., 2004). Paralleling the results in teleosts, effects on overall 
growth in an organism or its progeny tend to be variable. For example, American alligators 
hatching in Lake Apopka, a lake in Florida known for its elevated pesticide and agricultural 
pollution, were observed to have a lower body mass and condition index compared to hatchlings 
at a clean reference site. However, the alligators from Lake Apopka grew faster and were larger 
than the controls by 5 months of age (Moore et al., 2012). Additionally, rats exposed to BPA or 
genistein and mice exposed to DES had offspring that were greater in body weight than the 
control counterparts (Rubin et al., 2001; Newbold et al., 2004; Newbold et al., 2007).  
Additional Endocrine Effects 
 
     Several other hormones are well-known for interacting with the GH-IGF system (e.g., 
cortisol, thyroid hormone, insulin, somatostatin), and thus the effects of EDCs on other hormonal 
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systems should not be overlooked. Arukwe et al. (2000) showed that NP can penetrate the blood-
brain barrier in Atlantic salmon, indicating a possible effect on the hypothalamus-pituitary axis. 
E2 has been shown to reduce plasma T3 levels in teleosts (Mercure et al., 2001; McCormick et 
al., 2005), thus it is not surprising that EDCs, in particular estrogen mimetics, may affect the 
thyroid system. In fact, the effects of EDCs on the thyroid system are well-documented 
(reviewed in Brown et al., 2004 and Boas et al., 2012) and a few examples are subsequently 
presented. Arochlor and malathion exposure in Arctic charr and catfish, respectively, has been 
shown to decrease plasma levels of T4/T3 (Jorgensen et al., 2004; Lal et al., 2013). PCB 
exposure in the San Francisco Bay area was linked to depressed T4 concentrations in surfperch 
and sculpin (Brar et al., 2010). Similarly, PCBs were able to reduce plasma thyroid levels in rats 
(Gauger et al., 2004; Martin and Klassen, 2010), while DDT was able to produce the same effect 
in sparrows (Scollon et al., 2004). Additionally, in humans urinary phthalate concentrations were 
negatively associated with thyroid hormones, IGF-1, and childhood growth rates (Boas et al., 
2010).   
     The reproductive system has been well studied in regards to EDCs. For example, rainbow 
trout treated with NP showed decreased semen quantity and egg survival (Lahnsteiner et al., 
2005) and guppies treated with octylphenol had decreased testes growth (Toft and Baatrup, 
2001). At the molecular level, the relationship between the GH-IGF system and reproduction in 
complicated. Fathead minnows exposed to ethinylestradiol showed an increase in gonadal GH 
expression (Filby et al., 2006). E2 treatment during a pre-reproductive period additionally 
inhibited IGF-1 and increased expression of IGFBP2 in sea bream ovary. Conversely, during the 
reproductive stage of life, E2 stimulated IGF-1, IGF-2, and IGFR expression (Gioacchini et al., 
2005). These results indicate a possible effect on gametogenesis that is further supported at the 
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neuroendocrine level. Ethinylestradiol and NP were shown to increase the number of GnRH 
neurons in zebrafish embryos (Vosges et al., 2010). Additionally, BPA, NP, and E2 decreased 
GnRH3 neurons in medaka embryos (Lee et al., 2012). As IGF has been observed to regulate 
GnRH release and expression (Hiney et al., 2004), it is possible that the disruptive effects on the 
reproductive and growth systems is additive in nature.  
     While the majority of studies on EDCs and other endocrine systems have focused on 
reproductive and the thyroid hormones, some research has examined neuroendocrine responses. 
For example, BPA has been shown to affect NPY expression (Masuo et al., 2004). Additionally, 
TCDD exposure in rats has been shown to increase NPY, POMC, and CART mRNA (Fetissov et 
al., 2004). Fetissov et al. (2004) explained that these results may be due to an energy depletion 
status being activated by TCDD. As appetite and growth are intricately connected, the 
physiological effects of EDCs on both of these systems may be expected.  
     Endocrine disrupting compounds have likewise been suggested to affect metabolism, which is 
closely linked to growth. For example, BPA and DES treatment in pancreatic cells in vitro and in 
vivo lead to altered glucose and lipid metabolism (Alonso-Magdalena et al., 2005; Alonso-
Magdalena et al., 2006), while malathion has been shown to induce lipolysis in catfish (Lal et al., 
2013). Endocrine disrupting compounds such as BPA, DDT, and the organotin TBT (tributyltin 
chloride) can interfere with metabolism (e.g., adipogenesis) in vivo and in vitro thus contributing 
to metabolic diseases such as obesity. The effects of plasticizers, pesticides, pthlatates, dioxins 
and surfactants on metabolism have been shown to be regulated via interaction with nuclear 
receptor, peroxisome proliferator-activated receptor (PPAR), activity (Ward et al., 1998; Palut et 
al., 2001; Baillie-Hamilton, 2002; Grun et al., 2006; Takeuchi et al., 2006; McAllister et al., 
2009).  
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Signaling Mechanisms 
     The actions of EDCs may occur via alteration to a variety of genomic and nongenomic 
signaling mechanisms, many of which are poorly understood. Here we will focus on those 
mechanisms that may be related to xenoestrogens because they are the most studied type of EDC 
and because several classes of EDCs fall into the xenoestrogen category, thus providing us with a 
general picture of the biological mechanisms at work. To understand the signaling cascades 
activated or repressed, we must first understand the types of receptors thought to be responsible 
for the physiological actions of estrogen.  
     The estrogen receptor is a type I nuclear receptor that is found in the cytosol of the cell. The 
ER possesses six functional domains, A through F. The A and B domains have ligand-
independent transactivation function AF-1. The C domain is the DNA binding-domain and is 
involved in dimerization of the ER and its subsequent binding to the ERE. The D domain is the 
hinge domain, and the E domain is the ligand binding-domain. The function of the F domain 
remains unclear. ERs have multiple isoforms that are species-dependent. For example, rainbow 
trout possess both ERα and ERβ, each of which have two different isoforms distributed in a 
tissue-specific manner, with the highest distribution in tissues such as the liver and testes (Nagler 
et al., 2007). Generally, upon ligand binding, the ER dissociates from a heat shock protein, forms 
a homodimer or a heterodimer, translocates to the nucleus, and then binds to the ERE to 
subsequently activate or repress transcription (e.g., interaction of basal transcriptional machinery, 
chromatin modification, etc.) of estrogen-responsive genes. Additionally, the E2-ER complex 
may activate transcription factors such as activator protein-1 (Ap-1), which may then alter 
transcription (Kushner et al., 2000). Different subtypes and combinations of dimers, as well as  
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the tissue-specific nature of ERs, may account for the pleiotropic physiological effects of 
estrogen and certain EDCs.  
     Endocrine disrupting compounds including PCBS, phthalates, APEs, BPA, and 
phytoestrogens can bind to the estrogen receptor in mammals and teleosts, albeit with a much 
lower affinity (Sumpter and Jobling, 1995; Tremblay and Van der Kraak, 1998; Knudsen and 
Pottinger, 1999; Bonefeld-Jorgensen et al., 2001). For example, ethinylestradiol, zearanolone, 
genistein, DES, OP, NP, and BPA all induced enzyme activity in a luciferase reporter assay of 
rainbow trout ER, indicating the binding of these compounds to the receptor and subsequent 
transcriptional effects (Cosnefroy et al., 2009). While EDCs can bind to the ER, the elucidation 
of signaling mechanisms is further complicated by the structure of an EDC, as it alone cannot 
predict if a compound will bind to the ER. Additionally, while the parent EDC may not bind to 
the ER, metabolites of the parental compound may be capable of directly binding to the ER.      
     In addition to traditional nuclear responses, EDCs may elicit nongenomic responses in order 
to induce or inhibit signaling pathways and modulate gene expression (Fig. 2). Interference with 
the JAK-STAT pathway, which plays a critical role in IGF-1 expression, and/or the Erk and 
PI3K/Akt pathways, which are necessary for IGFR action, could lend support to the observed 
effects of EDCs on organismal growth. Nongenomic responses of EDCs may include the 
inhibition or activation of kinases such as Erk1/Erk2, PI3K, PKC, and PKA (Li et al., 2006). 
Membrane-bound ER may also activate various signaling cascades and second messengers 
(Nadal et al., 2000; Watters et al., 2000; Qin et al., 2004; Alonso-Magdalena et al., 2005). For 
example, coumestrol, NP, endosulfan, DDE, and dieldrin stimulated a rapid membrane-initiated 
cascade in a prolactinoma cell line known to possess abundant mER (Bulayeva and Watson,  
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Figure 2. Schematic diagram of possible environmental estrogen signaling mechanisms. As 
several endocrine disrupting compounds mimic estrogen, these compounds may work via similar 
mechanisms. Environmental estrogens represented include coumestrol, endosulfan, dieldrin, 
nonylphenol (NP), octylphenol (OP), bisphenol A (BPA), dichlorodiphenyldichloroethylene 
(DDE), dichlorodiphenyltrichloroethane (DDT), and polychlorinated biphenyls (PCBs). 
Environmental estrogens, EE; heat shock protein 90, Hsp90; estrogen receptor, ER; 
phosphorylated, P; transcription factor, TF; estrogen response element, ERE; growth hormone, 
GH; insulin-like growth factor, IGF. 
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2004). While these actions occurred via a mER, EDCs have also been shown to elicit 
physiological effects (e.g., growth, proliferation) via GPR30 (an orphan G protein-coupled 
receptor) (Filardo et al., 2000). BPA was observed to stimulate proliferation, growth, and 
migration of breast cancer cells via the activation of GPR30 (Pupo et al., 2012). Additionally, 
BPA has been shown to promote cellular proliferation via G-protein coupled receptors and the 
PKG pathway (Bouskine et al., 2009). 
     Endocrine disrupting compounds alter signaling cascades in a seemingly time-, concentration-
, and compound-dependent manner. Endpoint effects may include reduced cellular proliferation 
(via reduced aromatase activity), such as was observed in MCF-7 breast cancer cell lines treated 
with genistein (Brooks and Thompson, 2005). Specific examples of EDCs activating or 
inhibiting kinases include Erk1/Erk2 phosphorylation, which was activated by NP, but unable to 
be phosphorylated by treatment with BPA (Bulayeva and Watson, 2004). However, BPA, OP, 
NP, and E2 rapidly (within 30 minutes) activated ERK1/2 and PI3K in rat pituitary cells (Dang 
et al., 2009). E2, DES, coumestrol, endosulfan, and BPA can also lead to calcium influx and 
activation of MAPK (Watson et al., 2007). Additionally, DDT exposure has been observed to 
increase protein kinase activity (Enan et al., 1998). While results (time and concentration, 
activation and inhibition) may be variable, it is evident that EDCs can disrupt signaling 
pathways, thus affecting physiological endpoints such as cellular growth. 
     The interplay of EDCs and growth-specific signaling pathways is complex. Cytokine 
receptors, such as GHR, elicit their physiological effects (e.g., growth control, development, etc.) 
largely in part via the JAK-STAT pathway. DDT and PCBs have been shown to activate receptor 
tyrosine kinase pathways such as JAK-STAT (Shen and Novak, 1997; Enan et al., 1998). 
Conversely, E2 was observed to inhibit GH signaling via interactions with JAK2 (Leung et al., 
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2004). Similarly, normal GH-induced JAK-STAT activation was inhibited by E2 in a dose-
dependent manner in ovariectomized hypophysectomized rats. This appeared to be the result of 
suppression of GH-induced JAK2 phosphorylation and subsequent reduction in the 
transcriptional activity of STAT3 and STAT5 in hepatocytes (Murphy and Friesen, 1988).  
     In order to regulate GH signaling, the suppressors of cytokine signaling (SOCS) family may 
regulate cytokine receptor action. In mammals, there are eight SOCS family members, SOCS1-7 
and cytokine-inducible SH2-containing protein (CISH). The three most studied SOCS family 
members are SOCS-1, SOCS-2, and SOCS-3. SOCS-1 is responsible for regulating IFN-γ 
signaling, SOCS-2 regulates growth hormone signaling, and SOCS-3 is important for trophoblast 
differentiation and fetal erythropoiesis (Ilangumaran et al., 2004). Of interest, SOCS-2 has been 
implicated as a negative regulator of GHR signaling via binding to tyrosines on GHRs. GH has 
been observed to up-regulate the expression of SOCS-2 (Tollet-Egnell et al., 1999; Paul et al., 
2000; Rico-Bautista et al., 2004). Although the SOCS proteins appear to primarily inhibit 
cytokine receptor signaling, certain positive regulatory roles have also been demonstrated. For 
example, SOCS-2 can boost GHR signaling depending on the dose of GH administered (Favre et 
al., 1999). SOCS-2 may also play a role in IGF-1 signaling, as SOCS-2 has also been shown to 
bind to IGFRs (Dey et al., 1998).  
     The previously mentioned inhibition of the JAK-STAT signaling cascade may, in part, be due 
to E2 stimulation of SOCS-2 expression in hepatocytes (Jelinsky et al., 2003; Leung et al., 2003; 
Leong et al., 2004). Through the inhibition of JAK2 (Leung et al., 2003), multiple effector 
pathways may be affected downstream of the GHR. Additionally, E2 may suppress GHR 
signaling (i.e., JAK2/STAT5) via the activation of PLC (Fernandez et al., 1998). E2 may activate 
Gαq and Gβγ via a mER or GPR30. These subunits subsequently induce PLC activation (Filardo, 
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2002; Razandi et al., 2003). As estrogen is able to up-regulate SOCS-2, it is reasonable to 
suggest that EDCs, specifically those mimicking estrogen, may be able to elicit the same 
response. 
     Cross-talk with the GH-IGF system may be explained by multiple observations. First, the 
trout GH gene possesses a putative ERE in its promoter region (Melamed et al., 1998), thus 
presenting a target for transcriptional regulation. Additionally, direct interaction of the ER with 
signaling pathways has been evidenced by the co-immunoprecipitation of ERα with different 
components of the MAPK pathway in MCF-7 cells, thus indicating direct action on Ras/Erk 
kinases (Migliaccio, et al., 1996). IGF-1 can also phosphorylate ERα, thus activating the receptor 
and allowing the ER complex to elicit its physiological effects (Lanzino et al., 2008). In 
mammalian cell lines, cross-talk has been observed between estrogen receptors, IGF, and IGFR 
(Kahlert et al., 2000; Klotz et al., 2002; Mendez et al., 2006), thus eliciting downstream signaling 
effects and regulating the  expression of proteins involved in IGF-1 signal transduction (Bernard 
et al., 2006). Further evidence supporting the cross-talk between EDCs and growth pathways was 
provided by Yu et al. (2012), as E2 was able to rapidly stimulate MAPK signaling (essential for 
IGF signaling) and induced the phosphorylation of ERα in cells with a functional IGFR versus in 
those without a functional IGFR.  
     Other transcription factors may play a role in the genomic effects of EDCs on growth. The 
E2-ER complex can interact with AP-1 signaling. Jun and Fos family proteins dimerize to bind 
AP-1sites, then recruit coactivators such as p300/CBP to bind to the ER. AP-1 activity can be 
affected by EDCs including arochlor and DDT (Shekhar et al., 1997; Frigo et al., 2002), thus 
leading to potential down-stream effects on coactivators, corepressors, and transcription. Other 
transcription factors such as AhR, Kruppel-like factor-6, Sp1, Sp3, MSY-1, p53, and various 
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STATs may also be involved in the interplay of EDC and growth signaling (Schwartzbauer et al., 
1998; Schwartzbauer and Menon, 1998; Wang and Jiang, 2005; Yu et al., 1999; Wood et al., 
2005; Elango et al., 2006; Sarfstein et al., 2006), as the promoter regions of genes encoding 
GHR, IGF, and IGFR have been shown to be capable of binding to a variety of transcription 
factors.  
     As many of the signaling pathways involved in growth and estrogen signaling converge, the 
effects of genomic and nongenomic signaling may be additive. Further complicating the 
elucidation of the cross-talk between these pathways is that many of these studies have 
investigated effects of EDCs using immortal cancer cell lines, which undergo growth and 
proliferation at an accelerated rate, and thus may not accurately portray the mechanisms at work. 
Additional problems arise in generalizing the response(s) of cells to EDCS, as many of these 
response(s) appear to follow a non-traditional dose-response curve (Watson et al., 2007) and 
seem to be both tissue- and compound-dependent.  
Environmental Factors 
     While internal factors play a critical role in the response of an organism to EDCs, there are 
other environmental factors that may influence the response of an organism to low-level, chronic 
exposure to EDCs in terms of growth. In teleosts, GH levels are affected by external factors such 
as fasting, water temperature, and day length. Generally, increased temperature and extended 
photoperiod both tend to elevate growth in teleosts. Estrogen-responsive genes (e.g., ERα, ERβ, 
vitellogenin) are also sensitive to temperature and photoperiod. Specifically, Jin et al., (2011) 
found that exposure to ethinylestradiol and NP at different temperatures and photoperiods led to 
a significantly altered response in estrogen-responsive genes in medaka.  
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     In addition, processes that rely on environmental conditions, such as osmoregulation, may be 
affected by EDCs. During osmoregulation, mRNA expression levels and plasma levels of GH 
and IGF-1 increase following salt water exposure (Sakamoto et al., 1993; McCormick et al., 
2001; Agustsson et al., 2001; Shepherd et al., 2005; Nilsson et al., 2008). Additionally, 
heightened sensitivity to GH and IGF has been observed (Poppinga et al., 2007). The suggestion 
that EDCs may affect osmoregulation is not surprising given the close relationship between the 
GH-IGF system and its role in salt water readiness and hypoosmoregulatory ability (Sakamoto 
and McCormick, 2006). Previous studies have found that both NP and E2 reduced salinity 
tolerance of Atlantic salmon, (Madsen et al., 2004, McCormick et al., 2005; Lerner et al., 2007; 
Lerner et al., 2012), and sea bream (Carrera et al., 2007; Mancera et al., 2007) via disruption of 
the GH-IGF system (e.g., depressed IGF-1 mRNA, reduced GH binding capacity).  
Conclusion 
     Endocrine disrupting compounds can affect growth at multiple levels and generally appear to 
act in a tissue-and compound-dependent manner. While the effects on GH and IGF tend to 
parallel each other, these effects also seem to be highly variable. Moreover, signaling 
mechanisms evoked tend to be variable in response perhaps due to the diversity of ERs (i.e., 
mER, GPR30, ERα, ERβ). Further complicating matters is that responses appear to be related to 
stage of life, sex, environmental factors, etc. Age of an organism may also make a major 
difference in the effects of EDCs, as liver detoxification, DNA repair mechanisms, the immune 
system, and the blood brain barrier are not fully developed at the fetal/neonatal stage of life 
(Bern, 1992). Additionally, exposure to combinations of EDCs may dramatically affect cellular 
function as these mixtures may be 1000 times more potent than singularly acting EDCs (Arnold 
et al., 1996; Benachour et al., 2007). Even though regulatory agencies may restrict or ban the use  
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of these compounds, many are persistent in the ecosystem at chronically low levels. Expanded 
research of EDCs is critical in order to fully assess the threat posed to all organisms. 
Objectives 
     In a world with rapid technological advancements, we not only reap the benefits of these 
advancements, but are also faced with the consequences of our actions in terms of by-products 
and waste. Global production of EDCs has reached a staggering 400 million tons per year. While 
much of the research to date has focused on the reproductive and developmental consequences of 
EDCs, less attention has been directed towards how these compounds affect growth. There has 
been considerable research on the maintenance and modulation of growth and increasing 
evidence suggests that the regulation of growth occurs at several levels. The hypothesis of this 
dissertation is that EE modulate growth via the GH-IGF axis. Specifically, we will examine the 
following: 1) assess the actions of EE on osmoregulatory ability 2) examine the effects of EE on 
growth at the organismal and molecular level in vivo 2) assess the actions of EE on GH 
production, IGF-1 production, and IGF-1 responsiveness in vitro, and  4) elucidate the influence 
of EE on growth-related intracellular signaling pathways. The long-term impact of EE on 
population and community structure via epigenetic and transgenerational effects is not well 
understood. Moreover, virtually nothing has been reported regarding the effects of EE on 
organismal growth. In this project, rainbow trout will be used as a model system to evaluate the 
impact of EE on animal health as assessed by organismal growth. The findings of this project 
will establish whether or not these agents act as endocrine disruptors of growth in a wide-ranging 
aquatic species. While this work pertains specifically to rainbow trout, because the elements of 
the GH-IGF-1 system are highly conserved among vertebrates, the findings will have broad 
relevance to understanding the impact of EE in other aquatic and terrestrial species. Ultimately, 
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this work will inform policies and practices aimed at reducing the impact of EE on aquatic 
habitats and on the health of wildlife and humans. 
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CHAPTER 1: EFFECTS OF 17β-ESTRADIOL, 4-NONYLPHENOL, AND β-
SITOSTEROL ON THE GROWTH HORMONE-INSULIN-LIKE GROWTH FACTOR 
SYSTEM AND SEAWATER ADAPTATION OF RAINBOW TROUT 
(ONCORHYNCHUS MYKISS) 
Abstract 
 
     Previous studies show that successful adaptation of euryhaline teleost fish to seawater (SW) 
involves the GH-IGF system. The increasing occurrence, distribution, and concentration of 
environmental contaminants, including environmental estrogens (EE), in aquatic habitat over 
recent time may compromise hypoosmoregulatory ability of fish. In this study, we used rainbow 
trout (Oncorhynchus mykiss) to assess the effects of EE on the GH-IGF system and seawater 
adaptation. Juvenile trout (ca. 30 g) were exposed to either low (10 μg/l) or high (100 μg/l) 
concentrations of β-sitosterol (βS), 4-n-nonylphenol (NP), or 17β-estradiol (E2) for 28 days in 
fresh water (FW); after which, fish were exposed to 20‰ SW. Plasma chloride levels in control 
fish rose initially, then declined to initial levels after 48 h. By contrast, plasma chloride levels in 
all EE-treated groups except βS low increased and remained elevated over initial levels after 48 
h. Levels GH receptor 1(GHR1), GHR2, insulin-like growth factor-1 (IGF-1), and IGF-2 
mRNAs in liver of control fish increased 6-12 h after SW exposure. In gill, levels of GHR1, 
GHR2, IGF-1, IGF-2, IGF receptor 1A (IGFR1A) and IGFR1B mRNAs increased in control fish 
6-12 h after SW exposure. Levels of IGFR1A and IGFR1B mRNAs in white muscle and of 
IGFR1A mRNA in red muscle increased in control fish 6-12 h after SW exposure. Expression of 
all mRNAs in liver, gill, and red and white muscle declined from peak levels in control fish by 
48 h after transfer. Exposure of fish to βS, NP, and E2 abolished or attenuated normal salinity-  
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induced changes in the expression of GHR, IGF, and IGFR1 mRNAs in all tissues. These results 
indicate that EE reduces salinity adaptation by inhibiting components of the GH-IGF system. 
Introduction 
 
     Hypoosmotic regulation of euryhaline fish, including salmonids, is accompanied by an 
increase in the number and size of seawater (SW)-type chloride cells and by a corresponding 
increase in the expression and function of Na+, K+ ATPases (NKA), Na+, K+, 2Cl- cotransporters 
(NKCC), and Cl- channels in chloride cells (Evans and Clairborne, 2009). Considerable research 
has shown that SW adaptability of euryhaline fish is influenced by numerous hormones, 
including growth hormone (GH), insulin-like growth factor-1 (IGF-1), cortisol, and thyroid 
hormones (Mancera and McCormick, 1998; McCormick, 2001; Evans, 2002).  
     Increasing attention has been given to the GH-IGF system and its role in SW readiness and 
hypoosmoregulatory ability, which appear to be distinct from the actions of the GH-IGF system 
on growth (Sakamoto and McCormick, 2006; Klein and Sheridan, 2008). Plasma levels of GH 
and IGF-1 increase following exposure to SW accompanied by increased mRNA expression of 
the hormones (Sakamoto et al., 1993; McCormick et al., 2000; Agustsson et al., 2001; Shepherd 
et al., 2005; Nilsen et al., 2008). Heightened sensitivity to GH and IGFs also appears to 
accompany SW exposure, as expression of GH receptors (GHR) and type 1 IGF receptors 
(IGFR1) increase (Poppinga et al., 2007). In addition, GH and IGF-1 treatment increase salinity 
tolerance and chloride cell number as well as NKA and NKCC activity/biosynthesis 
(McCormick et al., 1991; Seidelin et al., 1999; Pelis et al., 2001). The GH-IGF system also 
appears important for the SW preparatory changes associated with salmonid smoltification. 
Levels of GH and IGF-1 increase during smoltification in association with increases in chloride 
cell size/number, NKA and NKCC activity (Young et al., 1989; McCormick et al., 2002). 
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     The increasing production, use, and disposal of an expanding array of chemicals that enter the 
environment pose a serious threat to terrestrial and aquatic animals, as well as to humans. Of 
particular concern is a broad spectrum of natural and synthetic compounds that mimic estrogen. 
Environmental estrogens (EE) include endogenous and synthetic animal estrogens (e.g., 17β-
estradiol), phytoestrogens (β-sitosterol), mycotoxins (e.g., zearalenone), organochlorine 
pesticides (e.g., DDT), polychlorinated biphenyls (PCBs), and alkylphenol polyethoxylates 
(APEs; e.g., 4-nonylphenol). The impacts of EE are magnified because they accumulate in 
tissues, have epigenetic effects and affect progeny, and are rapidly transferred through the food 
web (Hester and Harrison, 1999). Environmental estrogens have been found to disrupt a wide 
variety of reproductive processes in fish, amphibians, reptiles, and birds, including inhibited 
testicular growth, reduced sperm production, intersex gonads, reduced egg production, and 
altered reproductive timing and behavior (Tyler et al., 1998). Notably, 4-nonylphenol (NP) and 
β-sitosterol (βS) increase vitellogenin in the liver of male trout, an action that appears mediated 
via the estrogen receptor (Jobling and Sumpter, 1993; Tremblay and Van Der Kraak, 1998, 
1999). β-sitosterol also decreases plasma levels of sex steroids by reducing gonadal 
steroidogenesis in goldfish and rainbow trout (MacLatchy and Van Der Kraak, 1995).  
     Knowledge of the effects of EE on processes other than reproduction is just emerging. For 
example, 17β-estradiol (E2) and NP have been found to reduce salinity tolerance in Atlantic 
salmon smolts and reduce plasma levels of IGF-1 (Madsen et al., 2004, McCormick et al., 2005; 
Lerner et al., 2007a). The aims of the present study were to further elucidate the role of the GH-
IGF system in adaptation to increased salinity and to determine if the osmodisrupting effects of 
EE are mediated by alterations in the GH-IGF system. 
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Materials and Methods 
Experimental Animals 
     Juvenile rainbow trout of both sexes were obtained from Dakota Trout Ranch near 
Carrington, ND, and transported to North Dakota State University where they were maintained 
in 800-l circular tanks supplied with recirculated (100% replacement volume per day) 
dechlorinated municipal water at 14 ºC under a 12L:12D photoperiod. Fish were fed to satiation 
twice daily with AquaMax Grower (PMI Nutrition International, Inc., Brentwood, MO), except 
24-36 h before initiating experimental manipulations. 
Experimental Conditions 
     Fish (ca. 30 g) were anesthetized, measured, weighed, and transferred to 40-l glass aquaria 
(15 fish per tank) containing fresh water (FW) with or without an EE. Three estrogenic 
compounds were used: 17β-estradiol (Sigma, St. Louis, MO), 4-n-nonylphenol (AlfaAesar, Ward 
Hill, MA), and β-sitosterol (Calbiochem, San Diego, CA); the treatments groups were as follows: 
two doses of 17β-estradiol (10 μg/l and 100 μg/l), two doses of 4-nonylphenol (10 μg/l and 100 
μg/l), and two doses of β-sitosterol (10 μg/l and 100 μg/l). All compounds were dissolved in 
ethanol; the final concentration of ethanol did not exceed 0.007%. The vehicle control group 
received ethanol only. The water was well aerated and the tanks were kept at 14°C under a 12L: 
12D photoperiod. Twenty-four hours after transfer to aquaria, feeding was recommenced (1% 
body weight once per day) and continued throughout the FW exposure period; however; feeding 
was suspended 24 h prior to SW challenge. One-half the volume of each tank was removed and 
replaced with FW containing the appropriate treatment (added so as to maintain the desired final 
concentration of each test agent) every other day, in a manner similar to that described by 
Tremblay and Van Der Kraak (1999). Under these conditions, dissolved oxygen ranged from 8-
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10 mg/l, and ammonia did not exceed 0.25 ppm. Discarded water was filtered through activated 
charcoal before disposal. 
      After 28 days, fish were exposed to a salinity challenge. Water was removed from treatment 
tanks and replaced with SW (Instant Ocean, Aquarium Systems Inc., Mentor, OH) to achieve a 
final concentration of 20 ‰ (w/v). The replacement 20 ‰ SW did not contain estrogen treatment 
or vehicle, and the fish were not fed during the challenge period. Fish were sampled 0 h, 6 h, 12 
h, and 48 h following 20 ‰ SW exposure. At sampling, fish were anesthetized with 0.05% (v/v) 
2-phenoxyethanol, measured and weighed. Blood was collected with heparinized glass capillary 
tubes from the severed caudal vessels and centrifuged (5000g for 5 min). Plasma was collected 
and stored at -80 ºC for later analysis. Liver, gill filaments, red muscle, and white muscle 
samples were taken for mRNA analysis. All samples were immediately placed on dry ice and 
stored at -80 ºC. 
Plasma Chloride 
     Plasma chloride was measured by silver titration with a Buchler-Cotlove Chloridometer and 
using external standards. 
Quantitative Real-Time PCR 
     Frozen tissues were homogenized and total RNA was extracted using TRI reagent® 
(Molecular Research Center, Cincinnati, OH, USA) as specified by the manufacturer’s protocol. 
RNA pellets were dissolved in 40-100 μl RNase-free deionized water and total RNA was 
quantified by UV (A260) spectrophotometry. Total RNA was diluted with RNase-free deionized 
water to 100 ng/μl. RNA was reverse transcribed according to the manufacturer’s protocol in a 
10-μl reaction using 200 ng total RNA with an AffinityScript QPCR cDNA Synthesis Kit 
(Stratagene, La Jolla, CA).  
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     Steady-state mRNA levels of GHR1, GHR2, IGF-1, IGF-2, IGFR1A, and IGFR1B were 
determined by quantitative real-time PCR using a Stratagene Mx 3000p detection system 
(Stratagene, La Jolla, CA) as previously described (Very et al., 2005; Poppinga et al., 2007; 
Malkuch et al., 2008). Briefly, real-time PCR reactions were carried out for controls, standards, 
and samples in a 10 μl total volume (1 μl cDNA from reverse transcriptase reactions; 5 μl 2X 
Brilliant II Master Mix; 1.0 μl of each gene-specific probe, forward primer, and reverse primer at 
concentrations optimized for each RNA species; 1 μl RNase-free deionized water). Primer and 
probe sets for each of the genes are listed in Table 1. Cycling parameters were set as follows: 95° 
C for 10 min, and 50 cycles of 92° C for 15 s plus 58° C for1 min. Sample copy number was 
calculated from the threshold cycle number (CT), and the CT was related to a gene-specific 
standard curve followed by normalization to β-actin. 
Statistics 
     Quantitative data are expressed as means ± S.E.M. Statistical differences were analyzed by 
ANOVA followed by Duncan’s multiple range test using SigmaStat (SPSS, Chicago, IL). A 
probability of 0.05 was used to indicate significance. 
Results 
 
Body Characteristics 
 
     The effects of EE on the body characteristics of rainbow trout following a 28-day exposure in 
FW are shown in Table 2. Over the course of 28 days, juvenile trout in the control group grew 
significantly in terms of body length, and although body weight also increased, this change was 
not significant. Exposure to estrogenic compounds retarded growth to some extent. Although 
none of the estrogenic compounds affected body length, there was a trend (p = 0.26 E2 low; p =  
0.34 E2 high) for E2 to repress growth in terms of body weight compared to control-treated fish 
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and a significant (p < 0.05) depression of body weight observed in fish treated with the high dose 
of NP. Estrogenic compounds also tended to reduce the condition of fish. This was evidenced by 
the trend toward reduced condition observed in E2 (p = 0.18 E2 low; p = 0.30 E2 high) and low 
βS (p = 0.09)-treated fish and the significant (p < 0.05) decrease in condition observed in NP- 
treated fish. The hepatosomatic index (HSI) of all environmental estrogen-treated fish, except 
those treated with the high dose of βS, was significantly higher than that of control-treated fish. 
Plasma Chloride 
     The effects of EE on plasma chloride levels of rainbow trout during exposure to 20‰ SW are 
shown in Fig. 3. Interestingly, high doses of E2 and NP depressed plasma chloride levels over 
the course of the 28-day exposure period (cf. chloride at time 0 of SW challenge versus initial 
chloride levels before exposure to estrogenic compounds, which were 130±1.2 mM; significant 
only for E2, p < 0.05). Chloride levels in control-treated fish increased following SW exposure, 
reaching peak levels at 12 h; after which, chloride levels declined, and by 48 h the levels were 
similar to those observed at 0 h. By contrast, plasma chloride levels in all of the estrogen-treated 
fish, except those treated with the low dose of βS, increased following 20 ‰ SW exposure and 
remained elevated. 
GH-IGF System 
     The direct exposure of rainbow trout to 20‰ SW resulted in significant increases in steady-
state levels of mRNA encoding GHRs in liver. Two GHR-encoding distinct mRNAs were 
expressed in the liver of trout. The greatest effect of SW exposure was on the abundance of 
GHR1 mRNAs, which increased 287% 12 h after exposure; afterward, mRNA abundance 
declined substantially, but remained elevated compared to levels observed at 0 h (Fig. 4B).  
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Table 1. Primer and probe sets for real-time PCR 
Transcript Primer/Probe Sequence 
GHR1 Forward Primer 
Reverse Primer 
Probe 
5’-TGAACGTTTTTGGTTGTGGTCTA-3’ 
5’-CGCTCGTCTCGGCTGAAG-3’ 
5’FAM-CAAATGCAAGGATTCC-MGBNFQ3’ 
 
GHR2 Forward Primer 
Reverse Primer 
Probe 
5’-CATGGCAACTTCCCACATTCT-3’ 
5’-GCTCCTGCGACACAACTGTTAG-3’ 
5’FAM-TTCATTTGCCTTCTCC-MGBNFQ3 
 
IGF-1 Forward Primer 
Reverse Primer 
Probe 
5’-GTGGACACGCTGCAGTTTGT-3’ 
5’-CATACCCCGTTGGTTTACTGAAA-3’ 
5’FAM-AAAGCCTCTCTCTCCA-MGBNFQ3 
 
IGF-2 
 
Forward Primer 
Reverse Primer 
Probe 
5’-ACGTGTCGGCCACCTCTCTA-3’ 
5’-TGGGACATCCTGTTTGATTGTG-3’ 
5’FAM-AGATCATTCCCATGGTGC-MGBNFQ3’ 
 
IGFR1A 
 
Forward Primer 
Reverse Primer 
Probe 
5’-AGAGAACACATCCAGCCAGGTT-3’ 
5’-TCCTGCCATCTGGATCATCTT-3’ 
5’FAM-TGCCCCCGCTGAA-MGBNFQ3’ 
 
IGFR1B Forward Primer 
Reverse Primer 
Probe 
5’-CCTGAGGTCACTACGGGCTAAA-3’ 
5’-TCAGAGGAGGGAGGTTGAGACT-3’ 
5’FAM-ATCCGTCCCAGTCCT-MGBNFQ3’ 
 
β-actin 
 
Forward Primer 
Reverse Primer 
Probe 
5’-GGCTTCTCTCTCTCCACCTTCCA-3’ 
5’-AGGGACCAGACTCGTCGTAACTC-3’ 
5’VIC-TGCTTGCTGATCCACAT- MGBNFQ3’ 
 
Abbreviations: GHR, growth hormone receptor; IGF, insulin-like growth factor; IGFR, insulin-
like growth factor receptor 
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Figure 3. Effects of environmental estrogens (EE) on plasma chloride concentration in rainbow 
trout during acclimation to 20‰ seawater (SW). Fish were exposed to either a low (10 µg/l) or 
high (100 µg/l) dose of 17β-estradiol (E2), 4-nonylphenol (NP), or β-sitosterol (βS) in fresh 
water for 28 days, then sampled at various times after SW exposure. Data are presented as mean 
± SEM. (n=5-7).  For a given treatment, groups with different letters are significantly different 
(p<0.05); *indicates a significant difference (p<0.05) between the control and EE-treated groups 
at a given time. 
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Figure 4. Effects of environmental estrogens (EE) on the abundance of hepatic (A) growth 
hormone receptor 1 (GHR1) and (B) GHR2 mRNAs in rainbow trout during acclimation to 20 
‰ seawater (SW). Fish were exposed to either a low (10 µg/l) or high (100 µg/l) dose of 17β-
estradiol (E2), 4-nonylphenol (NP), or β-sitosterol (βS) in fresh water for 28 days, then sampled 
at various times after SW exposure. Data are presented as mean ± SEM. (n=5-7).  For a given 
treatment, groups with different letters are significantly different (p<0.05); *indicates a 
significant difference (p<0.05) between the control and EE-treated groups at a given time. 
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Figure 5. Effects of environmental estrogens (EE) on the abundance of hepatic (A) insulin-like 
growth factor-1 (IGF-1) and (B) IGF-2 mRNAs in rainbow trout during acclimation to 20 ‰ 
seawater (SW). Fish were exposed to either a low (10 µg/l) or high (100 µg/l) dose of 17β-
estradiol (E2), 4-nonylphenol (NP), or β-sitosterol (βS) in fresh water for 28 days, then sampled 
at various times after SW exposure. Data are presented as mean ± SEM. (n=5-7).  For a given 
treatment, groups with different letters are significantly different (p<0.05); *indicates a 
significant difference (p<0.05) between the control and EE-treated groups at a given time. 
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Seawater exposure also increased expression of GHR2 mRNA, which increased to maximum 
levels 6 h after exposure, then declined such that levels at 48 h were similar to those at 0 h (Fig. 
4A). Exposure to 20 ‰ SW similarly stimulated hepatic mRNA expression of IGF-1 and IGF-2. 
Expression of IGF-1 mRNA increased a maximum of 134% 12 h after SW exposure, then 
declined (Fig. 5A). Expression of IGF-2 mRNAs increased abruptly 6 h after exposure, then 
levels declined (Fig. 5B).  
     Notably, exposure to some of the EE depressed expression of GHR and IGF mRNAs such 
that their levels at 0 h were lower than those observed in control fish at 0 h; such depression was 
particularly pronounced with E2 and NP treatment (Fig. 4 and Fig. 5). Uniformly, exposure to all 
of the EE, E2, NP and βS, suppressed or abolished the normal SW-associated increases in the 
expression of hepatic GHR and IGF mRNAs. In particular, GHR1 mRNA levels rose following 
SW exposure in E2-treated fish, but the extent of the increases was significantly attenuated 
compared to those control fish (Fig 4A). Salinity-associated increases in levels of GHR2, IGF-1 
and IGF-2 were completely abolished by estrogen treatment (Fig. 4B and Fig. 5). 
     The patterns of expression of GH-IGF system components in the gill were similar to those 
observed in the liver. Exposure to 20 ‰ SW increased the abundance of both GHR mRNAs 
expressed in gill. GHR1 mRNA expression increased by 76% after 6 h, whereas GHR2 mRNA 
expression increased by 144% after 12 h; levels of both GHR mRNAs declined below maximal 
levels 48 h after exposure (Fig. 6). Exposure to 20 ‰ SW exposure also stimulated expression of 
IGF mRNAs in gill. IGF-1 mRNA increased to peak levels 12 h after SW exposure, then 
declined (Fig. 7A). Expression of IGF-2 mRNA also reached maximum levels 12 h after 
exposure, increasing 46%; after which, levels subsided (Fig. 7B). Two types 1 IGF receptors,  
 
75 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Effects of environmental estrogens (EE) on the abundance of (A) growth hormone 
receptor 1 (GHR1) and (B) GHR2 mRNAs in gill filaments of rainbow trout during acclimation 
to 20 ‰ seawater (SW). Fish were exposed to either a low (10 µg/l) or high (100 µg/l) dose of 
17β-estradiol (E2), 4-nonylphenol (NP), or β-sitosterol (βS) in fresh water for 28 days, then 
sampled at various times after SW exposure. Data are presented as mean ± SEM. (n=5-7).  For a 
given treatment, groups with different letters are significantly different (p<0.05); *indicates a 
significant difference (p<0.05) between the control and EE-treated groups at a given time. 
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Figure 7. Effects of environmental estrogens (EE) on the abundance of (A) insulin-like growth 
factor-1 (IGF-1) and (B) IGF-2 mRNAs in gill filaments of rainbow trout during acclimation to 
20 ‰ seawater (SW). Fish were exposed to either a low (10 µg/l) or high (100 µg/l) dose of 17β-
estradiol (E2), 4-nonylphenol (NP), or β-sitosterol (βS) in fresh water for 28 days, then sampled 
at various times after SW exposure. Data are presented as mean ± SEM. (n=5-7).  For a given 
treatment, groups with different letters are significantly different (p<0.05); *indicates a 
significant difference (p<0.05) between the control and EE-treated groups at a given time. 
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IFGR1A and IGFR1B, were expressed in gill. mRNA levels of both IGFR1s increased following 
SW exposure. Expression of IGFR1A mRNA increased a maximum of 65% 12 h after exposure, 
whereas levels of IGFR1B increased a maximum of 56% 6 h after exposure (Fig. 8). After 48 h 
of SW exposure, levels of both IGFR1 mRNAs declined to values similar to those observe 
initially at 0 h.  
     Similar to the situation observed in liver, exposure to EE depressed expression of GH-IGF 
system components in gill so that mRNA levels at 0 h were lower than those observed in control 
fish at 0 h. Such depression was particularly pronounced on the expression of GHR1, GHR2, 
IGF-2, and IGFR1B mRNAs, although there was some variation depending on the specific 
estrogenic compound (Fig. 6, Fig. 7, and Fig. 8). Also similar to the case in liver, exposure to all 
of the EE attenuated or blocked normal salinity-associated increases in GH-IGF system 
components. Expression of GHR1 and GHR2 mRNAs increased following 6-12 h of SW 
exposure in many of the estrogen-treated fish, but the extent of the increases was significantly 
attenuated compared to those of control fish (Fig. 6). Notably, GHR2 expression in fish treated 
with the high dose of E2 was lower than that in control fish (Fig. 6B). Salinity-associated 
increases in levels of IGF-1, IGF-2, IGFR1A, and IGFR1B mRNAs were completely blocked by 
estrogen treatment (Fig. 7 and Fig. 8). 
     As was the case with gill, two types of IGFR1s, IFGR1A and IGFR1B, were expressed in 
both red and white muscle. The abundance of both IGFR1 mRNAs increased in white muscle 
following SW exposure. IGFR1A mRNA expression levels increased a maximum of 47% 6 h 
after exposure, whereas expression of IGFR1B mRNA increased a maximum of 127% 6 h after 
exposure (Fig. 9). Expression of IGFR1 mRNAs also increased in red muscle following 20 ‰  
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Figure 8. Effects of environmental estrogens (EE) on the abundance of (A) IGF receptor 1A 
(IGFR1A) and (B) IGFR1B mRNAs in gill filaments of rainbow trout during acclimation to 20 
‰ seawater (SW). Fish were exposed to either a low (10 µg/l) or high (100 µg/l) dose of 17β-
estradiol (E2), 4-nonylphenol (NP), or β-sitosterol (βS) in fresh water for 28 days, then sampled 
at various times after SW exposure. Data are presented as mean ± SEM. (n=5-7).  For a given 
treatment, groups with different letters are significantly different (p<0.05); *indicates a 
significant difference (p<0.05) between the control and EE-treated groups at a given time. 
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Figure 9. Effects of environmental estrogens (EE) on the abundance of (A) IGF receptor 1A 
(IGFR1A) and (B) IGFR1B mRNAs in white muscle of rainbow trout during acclimation to 20 
‰ seawater (SW). Fish were exposed to either a low (10 µg/l) or high (100 µg/l) dose of 17β-
estradiol (E2), 4-nonylphenol (NP), or β-sitosterol (βS) in fresh water for 28 days, then sampled 
at various times after SW exposure. Data are presented as mean ± SEM. (n=5-7).  For a given 
treatment, groups with different letters are significantly different (p<0.05); *indicates a 
significant difference (p<0.05) between the control and EE-treated groups at a given time. 
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Figure 10. Effects of environmental estrogens (EE) on the abundance of (A) IGF receptor 1A 
(IGFR1A) and (B) IGFR1B mRNAs in red muscle of rainbow trout during acclimation to 20 ‰ 
seawater (SW). Fish were exposed to either a low (10 µg/l) or high (100 µg/l) dose of 17β-
estradiol (E2), 4-nonylphenol (NP), or β-sitosterol (βS) in fresh water for 28 days, then sampled 
at various times after SW exposure. Data are presented as mean ± SEM. (n=5-7).  For a given 
treatment, groups with different letters are significantly different (p<0.05); *indicates a 
significant difference (p<0.05) between the control and EE-treated groups at a given time. 
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SW exposure; however, only the change in IGFR1A levels was significant, which displayed a 
maximum increase of 54% 6 h after SW exposure (Fig. 10). After 48 h of 20 ‰ SW exposure, 
the abundance of both IGFR1 mRNAs in white and red muscle declined to values similar to 
those observe initially at 0 h.  
     Environmental estrogens tended to depress the mRNA expression of IGFR1s in red and white 
muscle in manner similar to that observed in gill such that mRNA levels at 0 h were lower than 
those observed in control fish at 0 h. Such depression was somewhat variable and depended on 
the specific estrogenic compound and its concentration (Fig. 9 and Fig. 10). Also similar to the 
observation in gill, exposure to all of EE attenuated or blocked normal salinity-associated 
increases in IGFR1 expression (Fig. 9 and Fig. 10). 
Discussion 
     The results of this study indicate that SW acclimation of rainbow trout involves transient 
increases in the expression of GHRs, IGFs (both IGF-1 and IGF-2), and type I IGFRs. These 
findings are consistent with previous observations on GHR, IGF-1, and IGFR1 expression by us 
(Poppinga et al., 2007) and on IGF-1 expression by others (cf. Sakamoto and McCormick, 2006), 
and extend our knowledge of the role of the GH-IGF system in SW adaptation. The observed 
increase in GHR and IGFR1 expression would lead to heightened sensitivity to GH and IGF in 
target organs—effects that combined with increased plasma levels of the hormones (Sakamoto et 
al., 1993; McCormick et al., 2000; Agustsson et al., 2001; Shepherd et al., 2005; Nilsen et al., 
2008) would accentuate their action during SW adaptation. Given that GH and IGF-1 enhance 
salinity tolerance via increases in chloride cell number, NKA and NKCC activity/biosynthesis 
(McCormick et al., 1991; Seidelin et al., 1999; Pelis et al., 2001), it is reasonable to suggest that  
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accentuated responsiveness to GH and IGF underlies, at least in part, the rapid 
hypoosmoregulatory ability of euryhaline fish. It is interesting to note that salinity adaption 
differentially affected the expression of subtypes encoding GHR (in liver and gill) and IGFR1 (in 
white muscle), but the significance of these observation is unclear. Distinct roles for GHR and 
IGFR subtypes in fish are suggested by their differential pattern of expression in embryos and 
adults, and that the patterns of their expression are differentially affected by nutritional state 
(Very et al., 2005; Norbeck et al., 2007; Malkuch et al., 2008). Recently, we showed that trout 
GHRs display differential ligand binding and agonist-induced regulation features (Reindl et al., 
2009). It is possible, therefore, that the observed salinity-induced changes in GHR and IGFR 
subtype expression are adaptive for activating hypoosmoregulatory responses. 
     The results of this study also indicate that exposure of rainbow trout to EE disrupts the GH-
IGF system—effects that were elicited at concentrations of E2, NP, and βS found in the 
environment (Blackburn and Wadlock, 1995; Cook et al., 1996; Hale et al., 2000). This was 
evidenced by several observations. First, initial mRNA levels of several GH-IGF system 
components (e.g., hepatic GHR2, hepatic IGF-1, gill GHR1 and GHR2, gill IGF-2, gill IGFR1B, 
red and white muscle IGFR1A, red and white muscle IGFR1B) were depressed by EE, 
particularly E2 and NP, compared to control-treated animals. Second, exposure to all of the EE 
used in the study attenuated or abolished the normal SW-associated increases in the expression 
of GHR and IGF mRNAs in liver as well as of GHR, IGF, and IGFR1 mRNAs in gill and of 
IGFR1 mRNAs in red and white muscle. Previous findings in Atlantic salmon showed that E2 
and NP had no effect on pituitary GH mRNA and that NP had a variable response (increase at 
one concentration, 2μg/g body weight injected intraperitoneally; no effect at lower or higher 
concentrations) on plasma GH (Yatedie and Male, 2002; McCormick et al., 2005). By contrast, 
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E2 and NP have been shown to decrease plasma IGF-1 levels in Atlantic salmon and rainbow 
trout (Arsenault et al., 2004; McCormick et al., 2005; Lerner et al., 2007a). Recently, it was 
reported that in developing tilapia 17α-ethinylestradiol reduced expression of IGF-1 in liver, 
brain, and gonad as well as of GH in brain (Shved et al., 2008). 
     Disruption of the GH-IGF system resulted in reduced hypoosmoregulatory ability of rainbow 
trout. This was evidenced by the general failure of plasma chloride levels in E2-, NP- 
and βS-treated fish to decline from peak values following exposure to 20‰ SW. It also was 
notable that plasma chloride values in the initial E2 high group were significantly depressed 
below those in the initial control group. We recognize that the magnitude of change in plasma 
chloride levels following SW exposure in this study was relatively small, which probably 
resulted from the use of 20‰ SW rather than full-strength SW, a choice we made to assure 
survival of small trout exposed to an abrupt change in salinity. The observed decrease in 
osmoregulatory ability is in agreement with previous studies that found that both NP and E2 
reduced salinity tolerance of Atlantic salmon (Madsen et al., 2004; McCormick et al., 2005; 
291 Lerner et al., 2007a, b). However, another study in Atlantic salmon using similar 
concentrations found that NP did not affect NKA activity unless presented in combination with 
atrazine (Moore et al., 2003). Carrera et al. (2007) found similar decreased salinity tolerance in 
gilthead sea bream when treated with NP. In light of effects of GH and IGF-1 on gill chloride 
cell number/size, NKA and NKCC activity discussed above (cf. Sakamoto and McCormick, 
2006), it is reasonable to suggest that GH insufficiency (in terms of reduced GH sensitivity in 
target organs) and IGF insufficiency (in terms of reduced IGF production/release and reduced 
IGF sensitivity in target organs) underlies, at least in part, the reduced hypoosmoregulatory 
ability of euryhaline fish exposed to EE. 
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     Disruption of the GH-IGF system also resulted in reduced growth of rainbow trout. This was 
evidenced by the tendency toward E2 to repress body weight as well as by the significant 
depression of body weight observed in fish treated with the high dose of NP compared to 
control-treated fish. Estrogenic compounds also tended to reduce the condition of fish, an effect 
that was most pronounced in NP-treated fish. Previous studies in Atlantic salmon smolts and 
developing tilapia also found that long-term exposure to E2 and NP reduced growth (Arsenault et 
306 al., 2004; Lerner et al., 2007a; Shved et al., 2008). The current study also revealed that E2-, 
NP-,and βS-treated trout display increased HSI, an observation consistent with previous findings 
in E2-treated gilthead sea bream (Carrera et al., 2007). The observed increase in HSI could be 
explained by hepatic vitellogenesis, which is stimulated by estrogenic compounds, including E2, 
NP, and β-sitosterol (Jobling and Sumpter, 1993; Tremblay and Van Der Kraak, 1998, Tremblay 
and Van Der Kraak, 1999). Taken together, these data indicate that EE reprogram fish to divert 
energy resources away from growth to reproduction. Given the involvement of the GH-IGF 
system in organismal growth (Klein and Sheridan, 2008), it is reasonable to suggest that the 
observed insufficiency of GH (in terms of reduced GH sensitivity in target organs) and of IGF 
(in terms of reduced IGF production and reduced IGF sensitivity in target organs) underlies, at 
least in part, the means by which EE reprogram the organism and suppress growth. 
     The cellular mechanism(s) by which EE disrupt the GH-IGF system is(are) not known, 
although a number of possibilities exist. E2, NP, and βS bind to estrogens receptors (ER) in fish 
(Tremblay and Van Der Kraak, 1998), forming an active transcription factor that can bind to 
promoter regions of genes possessing estrogen response elements (ERE) to promote their 
transcription. The transcription of the vitellogenin gene is stimulated by E2 in this manner, which 
explains the actions β-sitosterol and NP on hepatic vitellogenin synthesis (Tremblay and Van 
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Der Kraak, 1998, 1999). In mammals, it has been shown that E2 can influence GH action by 
regulating the expression of GHR, the promoter of which possesses an ERE-like motif and an 
adjacent Ap1 site that differentially interacts with ER subtypes, as well as by interacting with 
GHR signaling 327 pathways (e.g., JAK-STAT, ERK, PI3K/Akt)(Leung et al., 2004). 
Interference with the JAK-STAT pathway, which is important for IGF-1 expression, and/or the 
ERK and PI3K/Akt pathways, which are important for IGFR action, could explain the observed 
EE-induced disruption of the GH-IGF system. 
     In summary, the results of this study indicated that transient activation of GH-IGF system 
components, including increased expression of GHR1, GHR2, IGF-1, IGF-1, IGFR1A, and 
IGFR1B, accompany adaptation of rainbow trout to SW. The results also indicate that exposure 
of rainbow trout to environmental estrogen suppresses expression of GH-IGF systems 
components and leads to reduced growth and reduced hypoosmoregulatory ability. 
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Portions of this chapter have been published as follows: Hanson, A.H., Kittilson, J.D., 
Sheridan, M.A., 2013. General and Comparative Endocrinology, in press. 
CHAPTER 2: ENVIRONMENTAL ESTROGENS INHIBIT GROWTH OF RAINBOW 
TROUT (ONCORHYNCHUS MYKISS) BY MODULATING THE GROWTH HORMONE 
INSULIN-LIKE GROWTH FACTOR SYSTEM IN VIVO 
Abstract 
 
     The increasing production, use, and disposal of an expanding array of chemicals that enter the 
environment and mimic the action of estrogen pose a serious threat to terrestrial and aquatic 
animals as well as to humans.  Although such compounds, referred to as environmental estrogens 
(EE), have been found to disrupt a wide variety of developmental and reproductive processes in 
vertebrates, there is a paucity of information concerning their effects on organismal growth, 
particularly postembryonic growth.  In this study, we exposed juvenile rainbow trout 
(Oncorhynchus mykiss) in vivo to 17β-estradiol (E2), β-sitosterol (βS), or 4-n-nonylphenol (NP) 
to assess the effects of EE on overall organismal growth and on the growth hormone-insulin-like-
growth factor (GH-IGF) system. EE treatment significantly reduced food conversion, body 
condition, and body growth.  EE-inhibited growth resulted from alterations in peripheral 
elements of the GH-IGF system, which includes multiple GH receptors (GHRs), IGFs, and IGF 
receptors (IGFRs). In general, E2, βS, and NP reduced the expression of GHRs, IGFs, and 
IGFRs; however, the effects varied in an EE-, tissue-, element type-specific manner. These 
findings indicate that EEs disrupt post-embryonic growth by reducing GH sensitivity, IGF 
production, and IGF sensitivity. 
Introduction 
     Over the past few decades, the increased production, use, and disposal of an expanding array 
of chemicals has led to increased introduction of these compounds into the environment through 
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the air, soil, and water. Increasing research shows the deleterious effects of environmental 
contamination on aquatic and terrestrial plants, fish, amphibians, birds, and mammals (Hester & 
Harrison, 1998), including disruption of the endocrine system. Many endocrine disrupting 
compounds (EDCs) have been found to mimic the effects of endogenous estrogen. These 
compounds are typically called environmental estrogens (EEs) and include endogenous and 
synthetic animal estrogens (e.g., 17β-estradiol), phytoestrogens (β-sitosterol), mycotoxins (e.g., 
zearalenone), organochlorine pesticides (e.g., DDT), polychlorinated biphenyls (PCBs), and 
alkylphenol polyethoxylates (APEs; e.g., 4-n-nonylphenol). 
     The detrimental effects of EDCs can be observed at the organismal and molecular level and 
include developmental and reproductive effects (e.g., sex reversal, sterility, altered reproductive 
timing and behavior) that result in reduced fecundity (Kime et al., 1998). Several studies have 
demonstrated increased vitellogenin (an egg yolk precursor protein generally only produced by 
female fish in teleosts) synthesis in both males and females exposed to EEs, including 17β-
estradiol, wood-derived estrogens, and ethinylestradiol (Kidd et al., 2007; Mellanen et al., 1996; 
Tremblay and Van der Kraak, 1998). Similarly, 4-n-nonylphenol (at low concentrations) has 
been shown to inhibit testicular growth in rainbow trout (Jobling et al., 1996), while phytosterols 
have been linked as potential causative agents in reproductive dysfunction in both rainbow trout 
and goldfish (MacLatchy and Van der Kraak, 1995; Tremblay and Van der Kraak, 1998).  
     Other physiological effects of EDCs include effects on behavior, metabolism, and 
osmoregulation. For example, benzodiazepines, a group of persistent psychotherapeutic drugs, 
have been exhibited to alter the behavior of European perch, leading to more active, less social, 
and bolder fish (Brodin et al., 2013). It has been hypothesized that EDCs such as bisphenol A 
and DDT can interfere with metabolism (e.g., adipogenesis) thus contributing to metabolic 
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diseases such as obesity (Baillie-Hamilton, 2002; McAllister et al., 2009). Additionally, several 
studies have demonstrated that 4-n-nonylphenol exposure can reduce salinity tolerance of 
Atlantic salmon, rainbow trout, and gilthead sea bream (Carrera et al., 2007; Hanson et al., 2012; 
Lerner et al., 2007; Madsen et al., 2004; McCormick et al., 2005). Despite the fact that many 
EDCs are found at levels below the legal limit, the potential long-term impact of chronic 
exposure to low levels is not clear, especially given that EE are rapidly transferred through the 
food web, accumulate in tissues, and can have epigenetic effects (Baccarelli and Bollati, 2009; 
Phillips and Harrison, 1999; Skinner et al., 2010). 
     The maintenance and modulation of animal growth involves the coordination of external and 
internal cues that are transduced into chemical mediation that result in a host of physiological 
responses. The growth hormone (GH)-insulin-like growth factor-1 (IGF-1) system plays an 
integral role in the control of growth in vertebrates. GH, secreted chiefly from the pituitary, 
circulates throughout the body to stimulate the synthesis and secretion of IGF-1, primarily from 
the liver (Butler and LeRoith, 2001; Reindl and Sheridan, 2012; Wood et al., 2005). IGF-1 then 
acts on target cells to elicit effects such as cellular growth, proliferation, and differentiation 
(Butler and LeRoith, 2001; Reindl and Sheridan, 2012; Wood et al., 2005). Additionally, IGF-1 
may have growth-modulating effects that are independent of GH (Duan and Xu, 2005). The GH-
IGF-1 system has also been shown to play an important role in other physiological processes 
including energy metabolism, reproduction, and osmoregulation. 
     Despite extensive knowledge of the effects of EE on developmental and reproductive 
processes, very little is known about the effects of EE on organismal growth, particularly post-
embryonic growth. This study used rainbow trout as a model to examine the effects of EE on 
growth because of their well-characterized GH-IGF-1 system (Reindl and Sheridan, 2012) and 
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because of their wide geographic distribution in aquatic habitats. Specifically, the aim of the 
present study was to elucidate the role of EEs, specifically 17β-estradiol (E2), β-sitosterol (βS), 
and 4-n-nonylphenol (NP), on post-embryonic organismal growth and to determine if the effects 
of EE are mediated at the level of the GH-IGF system. 
Materials and Methods 
Experimental Animals 
     Juvenile rainbow trout of both sexes were obtained from Dakota Trout Ranch near 
Carrington, ND, and transported to North Dakota State University where they were maintained 
in 800-l circular tanks supplied with recirculated (100% replacement volume per day) 
dechlorinated municipal water at 14° C under a 12L:12D photoperiod. Fish were fed to satiation 
twice daily with AquaMax Grower (PMI Nutrition International, Inc., Brentwood, MO), except 
24-36 h before initiating experimental manipulations. All procedures performed were in 
accordance with the Guide for Care and Use of Laboratory Animals (National Research Council, 
Washington, DC) and approved by the North Dakota State University Institutional Animal Care 
and Use Committee. 
Experimental Conditions 
     To examine overall organismal growth, fish (ca. 50 g) were anesthetized with 0.05% (v/v) 2-
phenoxyethanol, measured, weighed, and tagged with Visible Implant Elastomer (VIE) tags 
(Northwest Marine Technology, Inc., Turnwater, WA). Fish were transferred to 40-l glass 
aquaria (10 fish per tank) containing only fresh water. Feeding was recommenced 24 h after 
transfer to aquaria (2% body weight once per day) and continued throughout the 28-d exposure 
period; however, feeding was suspended 24 h prior to final sampling. Fish were allowed to 
recover for 48 h before EE were added to the tanks. Three estrogenic compounds were used: 
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17β-estradiol (Sigma, St. Louis, MO) at 10 µg/l, β-sitosterol (Calbiochem, San Diego, CA) at 
100 µg/l, and 4-n-nonylphenol (AlfaAesar, Ward Hill, MA) at 100 µg/l. All compounds were 
dissolved in ethanol; the final concentration of ethanol did not exceed 0.007%. The vehicle 
control group received ethanol only. Every other day one-half the volume of each tank was 
removed and replaced with fresh water containing the appropriate EE treatment (added so as to 
maintain the desired final concentration of each test agent) similarly to that described by 
Tremblay and Van der Kraak (1998). The water was well aerated and the tanks were kept at 14° 
C under a 12L:12D photoperiod.  Over the course of the experiment, dissolved oxygen ranged 
from 8-10 mg/l and ammonia did not exceed 0.25 ppm. Discarded water was filtered through 
activated charcoal before disposal. Following the 28-d exposure, fish were again anesthetized 
with 0.05% (v/v) 2-phenoxyethanol, and weighed and measured according to tag location. 
     To investigate the molecular mechanisms affecting the GH-IGF axis, fish (ca. 50 g) were 
anesthetized with 0.05% (v/v) 2-phenoxyethanol, measured, weighed and transferred to 40-l 
glass aquaria (7 fish per tank) containing only fresh water. Feeding was recommenced 24 h after 
transfer to aquaria (2% body weight once per day) and continued throughout the 15-d exposure 
period; however, feeding was suspended 24 h prior to final sampling. Fish were allowed to 
recover for 48 h before EE were added to the tanks. Varying concentrations of the EE were used 
in different tanks: E2 (0.1 µg/l, 1.0 µg/l, 10 µg/l, 100 µg/l), βS (1.0 µg/l, 10 µg/l, 75 µg/l, 150 
µg/l), and NP (1.0 µg/l, 10 µg/l, 75 µg/l, 150 µg/l). All compounds were dissolved in ethanol; the 
final concentration of ethanol did not exceed 0.007%. The vehicle control group received ethanol 
only. Every other day one-half the volume of each tank was removed and replaced with fresh 
water containing the appropriate EE treatment (added so as to maintain the desired final 
concentration of each test agent) similar to the method described by Tremblay and Van der 
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Kraak (1998). The water was well aerated and the tanks were kept at 14° C under a 12L:12D 
photoperiod.  Over the course of the experiment, dissolved oxygen ranged from 8-10 mg/l and 
ammonia did not exceed 0.25 ppm. Discarded water was filtered through activated charcoal 
before disposal. At sampling, fish were again anesthetized with 0.05% (v/v) 2-phenoxyethanol. 
Blood was collected with heparinized glass capillary tubes from the severed caudal vessels and 
centrifuged (5000 x g for 5 min). Plasma was collected and stored at -80° C for later analysis. 
Liver, gill filaments, red muscle, and white muscle samples were taken for mRNA analysis. The 
remainder of the liver was taken for a radioreceptor assay. All samples were immediately placed 
on dry ice and stored at -80° C. 
Quantitative Real-Time PCR 
     Frozen tissues were homogenized and total RNA was extracted using TRI reagent ® 
(Molecular Research Center, Cincinnati, OH) according to the manufacturer’s protocol. RNA 
pellets were dissolved in 40-150 µL RNase-free deionized water. Total RNA was quantified by 
UV (A260) spectrophotometry and then diluted with RNase-free deionized water to 100 ng/µl. 
RNA was reverse transcribed in a 10-µl reaction using 200 ng total RNA with an AffinityScript 
QPCR cDNA Synthesis Kit (Stratagene, La Jolla, CA) as described by the manufacturer’s 
protocol. 
     As described previously (Malkuch et al., 2008; Poppinga et al., 2007; Very et al., 2005), 
steady-state mRNA levels of GHR1, GHR2, IGF-1, IGF-2, IGFR1A, and IGFR1B were 
determined by quantitative real-time PCR using a Stratagene Mx 3000p detection system 
(Stratagene, La Jolla, CA). Real-time PCR reactions were carried out for controls, standards, and 
samples in a 10 µl total volume (5 µl 2X Brilliant Master Mix; 0.5 µl of each gene-specific  
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Figure 11. Quantitative real-time PCR of mRNAs encoding (A) growth hormone receptor 1 
(GHR1) and GHR2, (B) insulin-like growth factor-1 (IGF-1) and IGF-2, (C) insulin-like growth 
factor receptor 1A (IGFR1A) and IGFR1B, and (D) vitellogenin (Vtg) obtained from rainbow 
trout. The amplification plot was used to determine threshold cycle number (CT). A standard 
curve (inset) of serial dilutions of known amounts of each cDNA was used to determine sample 
copy number, and then normalized to β-actin levels. Representative amplification plots are 
shown for selected tissues; NTC, no-template control. 
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probe, forward primer, and reverse primer at concentrations optimized for each RNA species). 
Cycling parameters were set as follows: 95° C for 10 min, and 50 cycles of 92° C for 15 s plus 
57° C for 1 min. Sample copy number was calculated from the threshold cycle number (CT), and 
the CT was related to a gene-specific standard curve following normalization to β-actin (Fig. 11). 
Cross hybridization was assessed by substituting alternate primer/probe sets in assays for each 
standard; no amplification was observed under these conditions. 
     cDNA standards for vitellogenin were synthesized by PCR. RT-PCR was used for the 
isolation of the cDNA sequence using an Advantage® 2 PCR Kit (BD Biosciences Clontech) 
following the manufacturer’s protocol. PCR was carried out using cDNA from rainbow trout 
liver with appropriate primers (forward: 5’-CTCCCCTGTTCTCTGCCATTT-3’; reverse: 5’-
ACTGCGTTGACTTCAGAAAACAA-3’). After an initial denaturation at 95° C for 1 min, a 30 
cycle-PCR was performed consisting of denaturation (95° C for 30 s), annealing (65°C for 30 s) 
and extension (72° C for 1 min) cycles. PCR products were then identified by electrophoresis on 
an agarose gel (1%) in 1X Tris-borate-EDTA (TBE) buffer followed by ethidium bromide 
staining. Following confirmation of desired product, PCR products were cloned into pGEM-T 
Easy Vector (Promega, Madison, WI, USA) and inserted into JM109 cells. Following 
purification, plasmids (75 fmol) were sequenced by the CEQ 2000 Dye Terminator Cycle 
Sequencing with Quick Start Kit (Beackamn Coulter, Fullerton, CA, USA) according to the 
manufacturer’s protocol. ABI Primer Express® Version 2 software was used to design gene-
specific oligonucleotide primers for real-time PCR based on known vitellogenin sequence using 
GeneTool software (BioTools, Inc., Edmonton, AB, Canada) and subsequently synthesized by 
Sigma-Genosys (The Woodlands, TX, USA). 
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     Steady-state mRNA levels of vitellogenin were determined by quantitative real-time PCR 
using PerfeCTa SYBR® Green SuperMix (Quanta Biosciences, Gaithersburg, MD, USA). Real-
time PCR reactions were carried out for controls, standards, and sampled in a 10 µl total volume 
(5 µL 2X SYBR Green SuperMix, 0.5 µL mixed primers, 2.5 µL nuclease free water). Cycling 
parameters were set as follows: 95° C for 3 min, 40 cycles of 95° C for 15 s plus 61° C for 45 
sec, and 1 cycle of 95° C for 1 min, 55° C for 30 sec, and 95° C for 30 sec. Sample copy number 
was calculated from the threshold cycle number (CT), and the CT was related to a gene-specific 
standard curve (Fig. 10). Real-time PCR of total RNA from liver showed a significant 
amplification of genes above no-template controls. Standard curves showed a linear relationship 
between log of the RNA copy number and CT.  
GH Binding  
     Hepatic microsomes were prepared from frozen liver and trout/salmon GH (sGH) was labeled 
with 125I-labeled sGH as described by Grey et al. (1990). Protein determination was completed 
using the Bio-Rad, Inc. (Hercules, CA) dye-binding method for microplates. Bovine serum 
albumin was used as the standard.  
     Saturation binding assays were conducted on hepatocytes by incubating (14° C, 3 h) 400 µL 
of cell suspension and 50 µL of 125-I-labeled sGH in either the presence or absence (for total 
binding) of cold sGH. Binding in the presence of sGH was taken as nonspecific binding. The 
incubation was terminated by centrifugation at 1,000 g (14° C, 15 min). Cells were washed three 
times with cold incubation medium to remove unbound hormone. The tubes were placed in 12 x 
75-mm gamma tubes for determination of radioactivity (Beckman 5500 gamma counter).   
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Statistics  
     Quantitative data are expressed as means ± S.E.M. Statistical differences were analyzed by 
ANOVA followed by Duncan’s multiple range test using SigmaStat (SPSS, Chicago, IL). A 
probability of 0.05 was used to indicate significance. 
Results 
Body Characteristics     
     Exposure to EE for 28 days had no effect on food intake (Table 3).  However, EE exposure 
significantly reduced food conversion (Table 3), which resulted in lowered body condition and 
growth retardation. Estrogenic compounds inhibited growth in terms of both relative body 
weight and relative body length, and although E2 and βS had similar growth-inhibiting effects, 
the effects of NP were the most pronounced of the EEs tested (Fig. 12A, 12B). Interestingly, the 
hepatosomatic index (HSI) of EE-treated fish tended to be higher than that control fish, an effect 
that was significant E2-treated fish (Table 3). As a positive biological indicator of estrogen 
exposure, vitellogenin mRNA was measured and an increase in vitellogenin mRNA (Fig. 12C) 
for all EE-treated fish was observed.  
Effects of EE on GHR mRNA and Functional Expression 
     The exposure of rainbow trout to EE for 15 days resulted in decreased levels of GHR mRNAs 
in liver. Two distinct GHR-encoding mRNAs are expressed in the liver, gill, red muscle, and 
white muscle of rainbow trout (Reindl and Sheridan, 2012). A significant decrease was observed 
in steady-state levels of mRNAs encoding GHR1 and GHR2 (Fig. 13A) in liver in a dose-
dependent manner for E2-treated fish. βS- and NP-treated trout exhibited decreases of 75% and 
72%, respectively, compared to control levels at the highest concentration for GHR1. Similarly,  
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Figure 12. Effects of environmental estrogens (EE) on relative growth in (A) weight and (B) 
length, and (C) hepatic vitellogenin abundance following 28-day exposure to EE. Fish were 
exposed to varying concentrations of 17β-estradiol (E2), β-sitosterol (βS), or 4-nonylphenol 
(NP). Data are presented as mean ± SEM (n=7). Means with different letters are significantly 
different (p<0.05) from each other. 
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Figure 13. Effects of environmental estrogens (EE) on the abundance of (A) hepatic, (B) gill 
filament, (C) red muscle, and (D) white muscle growth hormone receptor 1 (GHR1) and GHR2 
mRNAs and (E) liver binding capacity (Bmax) of GHRs in rainbow trout following 15-d 
exposure to EE. Fish were exposed to varying concentrations of 17β-estradiol (E2), β-sitosterol 
(βS), or 4-nonylphenol (NP). Data are presented as mean ± SEM (n=7). Means with different 
letters are significantly different (p<0.05) between the control and EE treatments for a given 
GHR subtype; *indicates a significant difference (p<0.05) between GHR subtypes within a given 
EE-treated group. 
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βS- and NP-treated groups showed decreased levels of GHR2, with βS decreasing to 78% and 
NP decreasing to 71% of control levels. Similar to results observed in liver, exposure of gill 
filaments to EE affected GHR1 and GHR2 (Fig. 13B) steady-state mRNA levels. GHR1 mRNA 
levels were suppressed, although not significantly, at high concentrations of E2 and βS when 
compared to the control fish. A dose-dependent decrease was observed in NP-treated fish for 
GHR1 and GHR2 mRNA levels in gill filaments. In red muscle, a dose-dependent decrease in 
βS-treated and NP-treated groups was observed for GHR1 mRNA levels (Fig. 13C). Notably, no 
significant decreases were observed in GHR2 mRNA levels in red muscle (Fig. 13C). White 
muscle, however, showed no significant decreased in GHR1 mRNA, whereas GHR2 mRNA 
(Fig. 13D) levels of NP-treated fish decreased to 73% of the control at the highest concentration 
of 150 µg/L.      
     Functional expression of GHR was determined by 125-I-GH binding to microsomes. Binding 
capacity in hepatic microsomes was reduced at the highest concentrations in all EE-treated tissue 
(Fig. 13E), which was consistent with the mRNA expression data. Binding capacity in hepatic 
microsomes decreased to 75% (E2), 77% (βS), and 71% (NP) of control values (Fig. 13E). EE 
treatment had no effect on binding affinity in liver (data not shown).  
Effects on IGF mRNA Expression 
     As was the case with GHRs, multiple rainbow trout tissues (e.g., liver, gill) possess two 
isoforms of IGF, IGF-1 and IGF-2 (Reindl and Sheridan, 2012). Exposure to EE suppressed 
hepatic and gill filament production of IGF mRNAs in a similar manner as that observed with 
GHR mRNAs. Hepatic IGF-1 and IGF-2 (Fig. 14A) mRNAs showed a dose-dependent decrease 
in all EE treatment groups, with the most pronounced effects being observed in E2- and NP-  
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Figure 14. Effects of environmental estrogens (EE) on the abundance of (A) hepatic and (B) gill 
filament insulin-like growth factor-1 (IGF-1) and IGF-2 mRNAs in rainbow trout following 15-d 
exposure to EE. Fish were exposed to varying concentrations of 17β-estradiol, β-sitosterol, or 4-
nonylphenol. Data are presented as mean ± SEM (n=7). Means with different letters are 
significantly different (p<0.05) for a given IGF type within a specific EE treatment group. 
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treated fish. The pattern of IGF mRNA expression observed in liver was similar to that observed 
in gill filaments, where IGF-1 and IGF-2 (Fig. 14B) mRNA expression decreased in a dose- 
dependent manner for E2- and NP-treated rainbow trout filaments. βS-treated fish, however, 
exhibited only a downward trend in  IGF-1 and IGF-2 mRNA expression levels. At the highest 
concentrations IGF-1 and IGF-2 mRNA levels decreased to 76% and 70%, respectively, of the 
control values for βS.  
Effects on IGFR mRNA Expression 
     Two types of IGFR1s, IGFR1A and IGFR1B, were expressed in gill, red muscle, and white 
muscle. Levels of both IGFR1s were greatest affected in gill filament, where IGFR1A decreased 
in a dose-dependent manner all treatment groups, except in βS treatment where mRNA levels 
decreased to only 83% of control values (Fig. 15A). No significant differences were observed in 
IGFR1B mRNA levels for any of the EE treatments, but all treatment groups exhibited a 
downward trend in IGFR1B mRNA (Fig. 15A). Effects on IGF sensitivity were less pronounced 
in muscle tissue. In red muscle a dose-dependent decrease in IGFR1A mRNA expression was 
observed in the NP-treated fish (Fig. 15B). Interestingly, IGFR1B mRNA expression decreased 
in a dose-dependent manner for both E2- and NP-treated fish (Fig. 15B). In white muscle, E2-
treated fish exhibited decreased IGFR1A expression to levels that were 66% of the control 
(Fig.15C), whereas IGFR1B mRNA levels decreased to 77% of the control at the highest 
concentrations (Fig. 15C). For βS-treated fish, IGFR1A expression decreased to levels 77% of 
the control at 150 µg/l, whereas no significant decrease was present with IGFR1B mRNA. NP-
treated fish had no significant differences among the concentrations.  
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Figure 15. Effects of environmental estrogens (EE) on the abundance of (A) gill filament, (B) red 
muscle, and (C) white muscle IGF receptor 1A (IGFR1A) and IGFR1B mRNAs in rainbow trout 
following 15-d exposure to EE. Fish were exposed to varying concentrations of 17β-estradiol, β-
sitosterol, or 4-nonylphenol. Data are presented as mean ± SEM (n=7). Means with different 
letters are significantly different (p<0.05) for a given IGFR subtype within a specific EE 
treatment group. 
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Discussion 
    Results from the current study indicate that EE inhibit post-embryonic growth, in terms of 
overall organismal growth (i.e. length, weight), and that the growth-inhibiting effects of EE  
result from alterations in peripheral aspect of the GH-IGF system, particularly GH sensitivity, 
IGF production, and IGF sensitivity. These effects were elicited at environmentally relevant 
concentrations of E2, βS, and NP (Blackburn and Wadlock, 1995; Cook et al., 1996; Hale et al., 
2000). 
     In terms of overall organismal growth, E2, βS, and NP lead to decreased organismal growth 
in terms of relative growth (weight and length). This is in agreement with our previous study 
(Hanson et al., 2012) and other studies that found that exposure to EE led to significant decreases 
in growth in developing (e.g., first month post-hatch) rainbow trout (Ashfield et al., 1998) and in 
developing tilapia exposed 10-100 days post-fertilization (Shved et al., 2008). In addition, long-
term exposure to E2 and NP has been shown to lead to reduced growth in Atlantic salmon smolts 
(Arsenault et al., 2004; Lerner et al., 2007). The effects of EE on organismal growth could be 
attributed to the exposure of rainbow trout during the juvenile life stage, a stage in which the fish 
are typically undergoing rapid growth (Mommsen, 2001). From a life history perspective, 
juveniles typically allocate energy resources towards growth prior to undergoing sexual 
maturation. Treatment at this critical life stage with a sex steroid such as estrogen, or a 
compound mimicking estrogen (e.g., β-sitosterol, nonlyphenol), may reprogram the fish to divert 
energy resources towards reproduction rather than growth.  
     Environmental estrogens reduced condition in fish, as in agreement with our previous study 
(Hanson et al., 2012) is which HSI was observed to increase in E2-treated fish. These data also 
are in agreement with previous findings by Carrera et al. (Carrera et al., 2007) in E2-treated 
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gilthead sea bream. Several estrogenic compounds act as agonists for the estrogen receptor and 
can induce the synthesis of vitellogenin, which could explain the increase observed in HSI 
particularly given our observation of an increase in vitellogenin mRNA for all EE-treated fish. 
While the current HSI data for βS- and NP-treated fish is not significantly different as previous 
studies have been (Hanson et al., 2012; Tremblay and Van der Kraak, 1998), the less robust 
response may simply be due to the lower affinity of βS and NP for the rainbow trout hepatic 
estrogen receptor when compared to endogenous estradiol (Tremblay and Van der Kraak, 1998; 
Cosnefroy et al., 2009). 
     The observed decrease in relative organismal growth was in agreement with our present 
results examining the GH-IGF system at the molecular level. The results of this study indicate 
that exposure of rainbow trout to EE disrupts the GH-IGF system at multiple tissue levels, as 
evidenced by several observations. First, EE attenuated hepatic GH sensitivity (e.g., GHR1, 
GHR2) in a concentration-dependent manner. Similar decreases in GH expression have been 
observed following chronic EE exposure in immediate post-hatch tilapia (Shved et al., 2008). As 
evidenced by a radioreceptor assay, EE also decreased functional expression of GHRs at the 
highest concentrations, which was in agreement with our mRNA data. GH also promotes hypo-
osmoregulatory ability of fish in seawater (SW); E2 and NP resulted in osmoregulatory failure of 
SW Atlantic salmon in conjunction with reduced GH binding capacity (Lerner et al., 2012). It 
appears, then, that EE impact growth throughout an animal’s life history, including during early 
development (embryonic; immediate post hatch) and post-embryonic juvenile stages. The age of 
an organism may play a critical role in the effects of EDCs, as liver detoxification mechanisms, 
DNA repair mechanisms, and the immune system are not fully developed at the earliest stages of 
life (Bern, 1992). 
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     Exposure to EE suppressed hepatic and gill filament production of IGF mRNAs in a manner 
similar to that observed with GHR mRNAs. Chronic exposure to EE appears to elicit similar 
effects as acute exposure, as gilthead sea bream injected with E2 and in vitro exposure in 
rainbow trout also showed decreased hepatic IGF-1 and IGF-2 mRNA levels (Carnevali et al., 
2005; Norbeck and Sheridan, 2011). This is in agreement with findings in Atlantic salmon and 
rainbow trout examining osmoregulatory dysfunction following exposure to E2 and NP that was 
attended by decreased plasma IGF-1 levels (Arsenault et al., 2004; Lerner et al., 2007; 
McCormick et al., 2005). Collectively, these data indicate that a negative feedback loop exists 
between E2 (and EE such as βS and NP) and peripheral elements of the GH-IGF system, which 
thereby decreases the growth-promoting actions of GH by affecting GH sensitivity and IGF 
synthesis. 
     Exposure to EE also suppressed gill filament and muscle production of IGFR mRNAs. The 
greatest effect of EE on IGFR1 expression was in gill filaments, where IGFR1A decreased in a 
dose-dependent manner in most treatment groups. While variable effects were observed in 
muscle tissue, generally there was a decrease in IGF sensitivity. This was in agreement with 
previous studies by our lab following in vitro treatment with E2 (Norbeck and Sheridan, 2012) 
and others in which ethinylestradiol exposure reduced IGFR mRNA in sexually maturing fathead 
minnows (Filby et al., 2007), suggesting that EE affect IGF sensitivity in adult organisms as well 
as juveniles.  
    These results indicate that EE inhibit post-embryonic growth by reducing GH sensitivity, IGF 
production, and IGF sensitivity. It should be noted that transient exposure to EE during early 
development can affect growth later in life. For example, transient NP exposure of trout 
hatchlings decreased growth up to one year after exposure (Ashfield et al., 1998). Such findings 
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are particularly alarming as recent evidence suggests that the epigenetic effects of EDCs are 
heritable across multiple generations, thus leading to a host of diseases states (Anway et al., 
2005; Anway and Skinner, 2006). 
     The endocrine control of growth is complex and is closely related to other processes such as 
development, immunity, reproduction, behavior, and osmoregulation, all of which vary 
depending on the life stage of a teleost. Following exposure to EE, many of these processes may 
be disrupted as there is an endocrine interrelationship between and among these physiological 
processes. Osmoregulation, for example, which relies upon the GH-IGF system (Sakamota and 
McCormick, 2006) has been shown to be negatively affected by exposure to E2, βS, and NP in 
rainbow trout and Atlantic salmon (Hanson et al., 2012; Lerner et al., 2007) suggesting EE may 
affect the action of GH on multiple levels (i.e. growth-promoting, osmoregulatory). Due to the 
highly conserved nature of the GH-IGF system among vertebrates, this study has broad relevance 
to understanding how EE may affect other species, including humans.  
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CHAPTER 3: ENVIRONMENTAL ESTROGENS INHIBIT THE EXPRESSION OF 
INSULIN-LIKE GROWTH FACTORS 1 AND 2 IN THE LIVER AND GILL OF 
RAINBOW TROUT (ONCORHYNCHUS MYKISS) IN VITRO 
Abstract 
     Rapid technological development over the past few decades has led to the increased 
introduction of an expanding array of chemicals into the environment via the air, water, and soil. 
Once in the environment, these compounds may pose a serious threat to terrestrial and aquatic 
vertebrates, as well as to humans. Fish in aquatic habitats are exposed to increasing 
concentrations and types of environmental contaminants, including environmental estrogens 
(EE). Previously, we exposed juvenile rainbow trout (ca. 50 g) in vivo to varying concentrations 
of 17β-estradiol (E2), β-sitosterol (βS), and 4-n-nonylphenol (NP) for 28 days (14 C; 12L:12D) 
and observed depressed food conversion, depressed growth, and altered expression of various 
elements of the growth hormone (GH)-insulin-like growth factor (IGF) system. In this study, we 
assessed the direct effects of EE on GH sensitivity as assessed by mRNA expression and 
functional expression of GH receptors (GHR), IGF production as assessed expression of IGF-1 
and IGF-2 mRNAs, and IGF sensitivity as assessed by mRNA expression and functional 
expression of IGF receptors (IGFR) in selected tissues. Environmental estrogens tested affected 
the expression of GHRs in a tissue- and compound-related manner. By contrast, E2, βS and NP 
inhibited the expression of both IGF-1 and IGF-2 in a time- and concentration-related manner in 
liver. Although the response evoked by all of the EEs was similar for hepatic IGF-1 and IGF-2 
mRNA expression, the potency and efficacy varied with EE; the rank order potency/efficacy was 
as follows: E2=NP> βS. E2, βS and NP also inhibited the expression of IGFR1A and IGFR1B 
mRNAs in a time- and concentration-related manner in gill and muscle; patterns for efficacy and 
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potency similar to those in liver also were observed in gill. These finding indicate that selected 
EEs can directly influence the growth of post-embryonic rainbow trout by inhibiting the 
synthesis of IGFs. 
Introduction 
 
     Numerous physiological processes in vertebrates are mediated by the growth hormone (GH)-
insulin-like growth factor-1 (IGF-1) system including growth, cellular differentiation, 
metabolism, reproduction, immune function, and behavior (Bjornsson et al., 2004; Duan, 1997; 
Hull and Harvey, 2000; Madsen and Bern, 1993; Mancera and McCormick, 1998; Norrelund, 
2005). One of the primary roles of the GH-IGF system is modulating growth at the cellular level. 
GH is secreted from the pituitary and circulates throughout the organism bound to growth 
hormone binding protein (GHBP), where it binds to growth hormone receptors (GHR) to initiate 
the synthesis and secretion of IGF-1 primarily from the liver (Butler and LeRoith, 2001; Wood et 
al., 2005), but also from other sites (e.g., gill, muscle). IGF travels throughout the organism 
bound to insulin-like growth factor binding proteins (IGFBP) and binds to its receptors (IGFR) to 
stimulate cellular growth, proliferation, and differentiation.  
     Somatic growth has been shown to be affected by gonadal steroids (Leung et al., 2004). 
Specifically, estrogen has been implicated as playing a role in growth by modulating the GH-IGF 
system. For example, studies have shown that 17β-estradiol can increase plasma GH in rainbow 
trout and tilapia (Holloway and Leatherland, 1997; Melamed et al., 1995). Further evidence of 
the interaction between estrogen and growth has been observed as in vivo treatment with 17β-
estradiol has been shown to decrease hepatic IGF-1 expression in tilapia, salmon, and gilthead 
sea bream (Carnevali et al., 2005; Davis et al., 2007; Lerner et al., 2007) as well as serum IGF-1 
in tilapia and salmon (Davis et al., 2007; Lerner et al., 2007). 
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     The increased production, use, and disposal of an expanding array of chemicals has led to 
increased introduction of these compounds into the environment through the air, soil, and water. 
These compounds originate from a multitude of sources (e.g., industry, agriculture, household 
cleaners, cosmetics, pharmaceuticals, personal care products, etc.), leading to continuous 
introduction and persistence of these chemicals in the environment (Daughton & Ternes, 1999). 
Increasing research shows the deleterious effects of environmental contamination on aquatic and 
terrestrial plants, fish, amphibians, birds, and mammals, including humans (Hester and Harrison, 
1999), often as a result of disruption of the endocrine system.   
     Environmental estrogens (EE) are a specific class of environmental contaminants that include 
endogenous and synthetic animal estrogens (e.g., 17β-estradiol), phytoestrogens (β-sitosterol), 
mycotoxins (e.g., zearalenone), organochlorine pesticides (e.g., DDT), polychlorinated biphenyls 
(PCBs), and alkylphenol polyethoxylates (APEs; e.g., 4-nonylphenol) (Turner, 1999). EE are 
particularly harmful to aquatic wildlife, primarily fish, and cause a variety of detrimental 
developmental and reproductive effects (e.g., sex reversal, sterility, altered reproductive timing 
and behavior) that result in reduced fecundity (Kime, 1998).  
     There is a robust amount of knowledge on the effects of EE on developmental and 
reproductive processes. However, very little has been reported regarding the effects of EE on 
growth at the molecular level. This study used rainbow trout as a model to examine the effects of 
EE on growth because of their well-characterized GH-IGF-1 system. Specifically, the aim of the 
present study was to further elucidate the role of EE (specifically 17β-estradiol, β-sitosterol, and 
4-n-nonylphenol) on growth at the molecular level and to determine if the effects of EE are 
mediated at the level of the GH-IGF axis in vitro. 
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Methods and Materials 
Experimental Animals 
     Juvenile rainbow trout of both sexes were obtained from Dakota Trout Ranch near 
Carrington, ND, USA and transported to North Dakota State University. Fish were maintained in 
800-l circular tanks supplied with recirculated (100% replacement volume per day) dechlorinated 
municipal water at 14° C under a 12L:12D photoperiod. Fish were fed to satiation twice daily 
with AquaMax Grower (PMI Nutrition International, Inc., Brentwood, MO), except 24 before 
experimental manipulations. All procedures were performed in accordance approved by the 
North Dakota State University Institutional animal Care and Use Committee. 
Experimental Conditions 
     To investigate the effects of EE on the GH-IGF system at the molecular level, fish (ca. 100 g) 
were anesthetized by immersion in 0.05% (v/v) 2-phenoxyethanol, measured, weighed and bled 
via the severed caudal vessel. Tissues (gill arches, liver, and white muscle) were removed, 
perfused ex vivo with 0.75% (w/v) saline solution, and stored in ice-cold Hank’s Buffered Salt 
Solution (in mM: 137 NaCl, 5.4 KCl, 4 NaHCO3, 1.7 CaCl2, 0.8 MgSO4, 0.5 KH2PO4, 0.3 
Na2HPO4, 10 HEPES, and 4 glucose; pH 7.6). Livers and muscle were cut into 1 mm
3 pieces 
while immersed in Hank’s on ice. Individual gill filaments were dissected from the arches while 
immersed in Hank’s on ice. All tissues were pooled and washed three times with Hank’s 
Balanced Salt Solution with 0.24% BSA, 2 ml Gibco MEM amino acid mix (50x)/100 mL, and 1 
mL Gibco nonessential amino acid mix (100x)/100 mL. Tissues were plated in 24-well culture 
plates (8-10 liver pieces, 12-15 gill filaments, 25-30 muscle pieces) containing 1-mL of Hank’s 
medium with 0.24% BSA, 2 ml Gibco MEM amino acid mix (50x)/100 mL, and 1 mL Gibco 
nonessential amino acid mix (100x)/100 mL and preincubated at 14 °C under 100% O2 while 
being shaken at 100 rpm in a gyratory shaker. Following the 3 h preincubation, media was 
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removed and tissues were subjected to either a time course or a dose course of three estrogenic 
compounds: 17β-estradiol (Sigma, St. Louis, MO), β-sitosterol (Calbiochem, San Diego, CA) 
and 4-n-nonylphenol (AlfaAesar, Ward Hill, MA). All compounds were dissolved in ethanol; the 
final concentration of ethanol did not exceed 0.007%. For the dose course the following 
treatments were administered for all tissues: E2 (0.1 µg/l, 1.0 µg/l, 10 µg/l, 100 µg/l), βS (1.0 
µg/l, 10 µg/l, 75 µg/l, 150 µg/l), and NP (1.0 µg/l, 10 µg/l, 75 µg/l, 150 µg/l) for 6 h. A time 
course of 0 h, 3 h, 6 h, 12 h, and 24 h was used to examine long-term genomic effects at 
concentrations of 10 µg/l (E2) or 75 µg/l (βS, NP) on gill and liver. Due to tissue viability issues, 
a time course was not performed on muscle. Following incubation, tissues were immediately 
placed on dry ice and stored at -80° C for later mRNA and binding analyses. 
Quantitative Real-Time PCR 
     Frozen tissues were homogenized and total RNA was extracted using TRI reagent ® 
(Molecular Research Center, Cincinnati, OH) according to the manufacturer’s protocol. RNA 
pellets were dissolved in 40-150 µL RNase-free deionized water. Total RNA was quantified by 
UV (A260) spectrophotometry and then diluted with RNase-free deionized water to 100 ng/µl. 
RNA was reverse transcribed in a 10-µl reaction using 200 ng total RNA with an AffinityScript 
QPCR cDNA Synthesis Kit (Stratagene, La Jolla, CA) as described by the manufacturer’s 
protocol. 
     As previously described (Very et al., 2005; Poppinga et al., 2007; Malkuch et al., 2008), 
steady-state mRNA levels of GHR1, GHR2, IGF-1, IGF-2, IGFR1A, and IGFR1B were 
determined by quantitative real-time PCR using a Stratagene Mx 3000p detection system 
(Stratagene, La Jolla, CA). Real-time PCR reactions were carried out for controls, standards, and 
samples in a 10 µl total volume (5 µl 2X Brilliant Master Mix; 0.5 µl of each gene-specific 
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probe, forward primer, and reverse primer at concentrations optimized for each RNA species). 
Cycling parameters were set as follows: 95° C for 10 min, and 50 cycles of 92° C for 15 s plus 
57° C for 1 min. Sample copy number was calculated from the threshold cycle number (CT), and 
the CT was related to a gene-specific standard curve following normalization to β-actin.  
     As previously described (Hanson et al., in press) steady-state mRNA levels of vitellogenin 
were determined by quantitative real-time PCR using PerfeCTa SYBR® Green SuperMix 
(Quanta Biosciences, Gaithersburg, MD, USA). Real-time PCR reactions were carried out for 
controls, standards, and sampled in a 10 µl total volume (5 µL 2X SYBR Green SuperMix, 0.5 
µL mixed primers, 2.5 µL nuclease free water). Cycling parameters were set as follows: 95° C 
for 3 min, 40 cycles of 95° C for 15 s plus 61° C for 45 sec, and 1 cycle of 95° C for 1 min, 55° 
C for 30 sec, and 95° C for 30 sec. Sample copy number was calculated from the threshold cycle 
number (CT), and the CT was related to a gene-specific standard curve. Conditions were 
optimized for the dissociation curve indicating primer-dimer formation was absent. 
Binding  
     Hepatic, gill filament, and muscle microsomes were prepared and trout/salmon GH (sGH) and 
IGF were labeled with 125I-label (MP Biomedicals, Inc, Irvine, CA) as described previously 
(Gray et al., 1990, Parrizas et al., 1995). GH and IGF were purchased from GroPep, Ltd. 
(Adelaide, Australia). Protein determination was completed using the Bio-Rad, Inc. (Hercules, 
CA) dye-binding method for microplates. Bovine serum albumin was used as the standard. 
     Saturation binding assays were conducted on hepatocytes by incubating (14° C, 3 h) 400 µL 
of cell suspension and 50 µL of 125-I-labeled sGH in either the presence or absence (for total 
binding) of cold sGH. Binding in the presence of sGH was taken as nonspecific binding. The 
incubation was terminated by centrifugation at 1,000 g (14° C, 15 min). Cells were washed with 
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cold incubation medium to remove unbound hormone. The tubes were placed in 12 x 75-mm 
gamma tubes for determination of radioactivity (Beckman 5500 gamma counter).   
Statistics  
     Quantitative data are expressed as means ± S.E.M. Statistical differences were analyzed by 
ANOVA followed by Duncan’s multiple range test using SigmaStat (SPSS, Chicago, IL). A 
probability of 0.05 was used to indicate significance. 
Results 
 
Effects of EE on Vitellogenin mRNA Expression 
     As a biological indicator of exposure to EE, vitellogenin mRNA levels were measured in 
hepatic tissue cultures. A significant increase was observed in all three EE-treated groups (Fig. 
16) at the selected concentrations (10 µg/L E2, 75 µg/L βS, 75 µg/L NP). Specifically, E2-
treated rainbow trout exhibited a 2186-fold increase (over control) in vitellogenin steady-state 
mRNA levels, whereas fish exposed to βS and NP displayed a 33- and 456-fold increase, 
respectively.   
Effects of EE on mRNA and Functional Expression of GHRs 
     The exposure of rainbow trout tissue cultures to EE for various concentrations and times was 
tissue-and compound-dependent. Two distinct GHR-encoding mRNAs, GHR1 and GHR2, are 
expressed in the liver, gill, and white muscle of rainbow trout. E2 and NP decreased levels of 
GHR mRNAs in a time- (Fig. 17A) and concentration-(Fig. 17B) related manner in liver, while 
βS-treated liver pieces remained unchanged. A significant decrease was observed in steady-state 
levels of mRNAs encoding GHR 1 and GHR 2 (Fig. 17A) in liver after 6 h for E2- and NP-
treated hepatocytes. By 24 h, E2- and NP-treated tissue decreased to 61% and 69% (GHR1) and 
63% and 68% (GHR2), respectively, of control levels. At the highest concentrations, mRNA  
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Figure 16. Effects of environmental estrogens (EE) on the abundance of hepatic vitellogenin 
mRNA for 10 µg/L 17β-estradiol (E2), 75 µg/L β-sitosterol (βS), or 75 µg/L 4-nonylphenol (NP) 
for 6 h. Data are presented as mean ± SEM (n=6). Means with different letters are significantly 
different (p < 0.05) different from each other. 
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Figure 17. Effects of environmental estrogens (EE) on the abundance of hepatic growth hormone 
receptors (GHRs) in rainbow trout incubated in vitro. Liver pieces were incubated for (A) 
various times with 10 µg/L 17β-estradiol (E2), 75 µg/L β-sitosterol (βS), or 75 µg/L 4-
nonylphenol (NP) or (B) various concentrations for 6 h. Data are presented as mean ± SEM 
(n=6). For a given GHR subtype within a treatment, means with different letters are significantly 
different (p < 0.05) different from each other. * indicates a significant difference (p < 0.05) 
between two GHR subtypes within a treatment group. 
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abundance of GHR1 decreased to 62% and GHR2 mRNA abundance decreased to 73% of 
control values in E2-treated liver tissue, whereas GHR1 decreased to 72% of control values and  
GHR2 decreased to 75% of control values in NP-treated tissue (Fig. 17B). Exposure of gill 
filaments to EE did not appear to significantly suppress nor elevate GHR1 or GHR2 steady-state 
mRNA levels in a time- or concentration-dependent manner for any treatment group (Fig. 18A, 
18B). A concentration-dependent decrease was observed for GHR1 mRNA abundance in muscle 
tissue following treatment with E2, βS, and NP. However, GHR2 mRNA suppression was only 
significant in E2- and NP-treated groups, where levels decreased to 74% and 62%, respectively, 
of control values (Fig. 19).   
     Functional expression of GHR was determined by 125-I-GH binding to microsomes. Binding 
capacity in hepatic microsomes was reduced by over 40% in both E2- and NP-treated tissue (Fig. 
20), which was consistent with the mRNA expression data. Binding capacity in gill, although 
suppressed, was not significantly different for any of the EE treatment groups (Fig. 20). Binding 
capacity in white muscle microsomes decreased to 73% (E2), 77% (βS), and 68% (NP) of 
control values (Fig. 20). Environmental estrogen treatment had no effect on binding affinity in 
liver, gill, or white muscle (data not shown).  
Effects of EE on IGF mRNA Expression 
    The direct effects of EE on IGF-1 and IGF-2, the two forms of IGF found in rainbow trout, 
was also assessed in vitro for liver and gill tissue. Exposure to EE suppressed hepatic and gill 
filament production of IGF mRNAs in a concentration- and time-dependent manner for all EE 
tested. IGF-1 mRNA expression in hepatocytes declined rapidly with maximum suppression 
observed at 24 h, where mRNA abundance decreased to 34% (E2), 61% (βS), and 49% (NP) of 
control values (Fig. 21), while IGF-2 mRNA expression decreased to 38% (E2), 54% (βS), and  
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Figure 18. Effects of environmental estrogens (EE) on the abundance of gill filament growth 
hormone receptors (GHRs) in rainbow trout incubated in vitro. Gill filaments were incubated for 
(A) various times with 10 µg/L 17β-estradiol (E2), 75 µg/L β-sitosterol (βS), or 75 µg/L 4-
nonylphenol (NP) or (B) various concentrations for 6 h. Data are presented as mean ± SEM 
(n=6). For a given GHR subtype within a treatment, means with different letters are significantly 
different (p < 0.05) different from each other. * indicates a significant difference (p < 0.05) 
between two GHR subtypes within a treatment group. 
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Figure 19. Effects of environmental estrogens (EE) on the abundance of the abundance of muscle 
growth hormone receptors (GHRs) in rainbow trout incubated in vitro. Muscle pieces were 
incubated for various concentrations for 6 h. Data are presented as mean ± SEM (n=6). For a 
given GHR subtype within a treatment, means with different letters are significantly different (p 
< 0.05) different from each other. * indicates a significant difference (p < 0.05) between two 
GHR subtypes within a treatment group. 
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Figure 20. Effects of 17β-estradiol (E2), β-sitosterol (βS), or 4-nonylphenol (NP) on binding of 
125I-salmonid growth hormone (GH) to microsomes prepared from liver, gill filaments, and 
muscle of rainbow trout. Liver pieces, gill filaments, and muscle pieces were incubated in vitro 
with 10 µg/L 17β-estradiol (E2), 75 µg/L β-sitosterol (βS), or 75 µg/L 4-nonylphenol (NP) for 6 
h. Illustrated is the binding capacity (Bmax) presented as mean ± SEM (n=6). For a given tissue, 
means with different letters are significantly (p < 0.05) different from each other. 
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Figure 21. Effects of environmental estrogens (EE) on the abundance of the abundance of 
hepatic insulin-like growth factors (IGFs) in rainbow trout incubated in vitro. Liver pieces were 
incubated for (A) various times with 10 µg/L 17β-estradiol (E2), 75 µg/L β-sitosterol (βS), or 75 
µg/L 4-nonylphenol (NP) or (B) various concentrations for 6 h. Data are presented as mean ± 
SEM (n=6). For a given IGF type within a treatment, means with different letters are 
significantly different (p < 0.05) different from each other. * indicates a significant difference (p 
< 0.05) between two IGFs within a treatment group. 
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49% (NP) of control values (Fig. 21A). Similarly, expression of IGF-1 and IGF-2 mRNA was 
suppressed in a concentration-dependent manner for all three EE with maximum inhibition 
observed at 100 µg/L E2, 150 µg/L βS, and 150 µg/L NP (Fig. 21B). In gill, similar results were 
observed, with suppression of IGF-1 and IGF-2 generally apparent after 3 h and maximum 
suppression levels reached at 24 h (Fig. 22A) for E2- and NP-treated groups. In E2-treated fish, 
significant decreases in IGF-1 and IGF-2 were evident by 1 µg/L E2 and persisted through 100 
µg/L E2 (Fig. 22B). In βS-treated fish IGF-1 was significantly down-regulated at concentrations 
of 75 µg/L and 150 µg/L βS (Fig. 22B). In NP-treated fish, IGF-1 and IGF-2 mRNA abundance 
was significantly lowered through the entire concentration course (Fig. 22B).   
Effects of EE on mRNA and Functional Expression of IGFRs 
     Two types of IGFR1s, IGFR1A and IGFR1B, are expressed in gill and white muscle. Levels 
of IGFR1A and IGFR1B mRNA declined in a similar manner for E2- and NP-treated gill 
filaments, with maximum depression observed at 24 h (Fig. 23A). In E2-treated filaments, 
IGFR1A mRNA expression decreased to 61% of the control at 100 µg/L and NP-treated 
filaments showed a 65% decrease in IGFR1A mRNA expression when compared to control 
levels; βS, however, remain unchanged (Fig. 23A). IGFR1B mRNA expression was only 
depressed in the E2-treated gill filaments in the concentration course (Fig. 23B). IGFR1A 
expression significantly decreased in E2- and NP-treated muscle pieces at the highest 
concentrations, whereas IGFR1B mRNA expression was only significantly affected in NP-
treated muscle tissue (Fig. 24). 
     Functional expression of IGFR was determined by 125-I-IGF binding to microsomes. Binding 
capacity in gill microsomes was reduced significantly in NP-treated tissue (Fig. 25). Although  
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Figure 22. Effects of environmental estrogens (EE) on the abundance of the abundance of gill 
filament insulin-like growth factors (IGFs) in rainbow trout incubated in vitro. Gill filaments 
were incubated for (A) various times with 10 µg/L 17β-estradiol (E2), 75 µg/L β-sitosterol (βS), 
or 75 µg/L 4-nonylphenol (NP) or (B) various concentrations for 6 h. Data are presented as mean 
± SEM (n=6). For a given IGF type within a treatment, means with different letters are 
significantly different (p < 0.05) different from each other. * indicates a significant difference (p 
< 0.05) between two IGFs within a treatment group. 
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Figure 23. Effects of environmental estrogens (EE) on the abundance of the abundance of gill 
filament insulin-like growth factor receptors (IGFRs) in rainbow trout incubated in vitro. Gill 
filaments were incubated for (A) various times with 10 µg/L 17β-estradiol (E2), 75 µg/L β-
sitosterol (βS), or 75 µg/L 4-nonylphenol (NP) or (B) various concentrations for 6 h. Data are 
presented as mean ± SEM (n=6). For a given IGFR subtype within a treatment, means with 
different letters are significantly different (p < 0.05) different from each other. * indicates a 
significant difference (p < 0.05) between two IGFR subtypes within a treatment group. 
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Figure 24. Effects of environmental estrogens (EE) on the abundance of the abundance of muscle 
insulin-like growth factor receptors (IGFRs) in rainbow trout incubated in vitro. Muscle pieces 
were incubated for various concentrations for 6 h. Data are presented as mean ± SEM (n=6). For 
a given IGFR subtype within a treatment, means with different letters are significantly different 
(p < 0.05) different from each other. * indicates a significant difference (p < 0.05) between two 
IGFR subtypes within a treatment group 
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Figure 25. Effects of 17β-estradiol (E2), β-sitosterol (βS), or 4-nonylphenol (NP) on binding of 
125I-insulin-like growth factor (IGF) to microsomes prepared from gill filaments and muscle of 
rainbow trout. Gill filaments and muscle pieces were incubated in vitro with 10 µg/L 17β-
estradiol (E2), 75 µg/L β-sitosterol (βS), or 75 µg/L 4-nonylphenol (NP) for 6 h. Illustrated is the 
binding capacity (Bmax) presented as mean ± SEM (n=6). For a given tissue, means with 
different letters are significantly (p < 0.05) different from each other. 
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suppressed, binding capacity in E2- and βS-treated tissues was not significantly decreased. 
Binding capacity in white muscle microsomes significantly decreased to 73% (E2) and 67%  
(NP) of control values (Fig. 25). EE treatment had no effect on binding affinity in gill or white 
muscle (data not shown).  
Discussion 
     This study examined the influence of three EE, E2, βS, and NP, on the GH-IGF system in 
rainbow trout. Previously, we discovered that EE can decrease organismal growth in rainbow 
trout, which was in agreement with observations in platyfish and swordtail exposed to EE such 
as nonylphenol (Magliulo, et al., 2002). In order to further investigate this decrease in organismal 
growth, we examined the effects of EE on the GH-IGF system. The results of our study indicate 
that EE have a direct effect on growth at the molecular level in a tissue- and compound-
dependent manner, lending support to our hypothesis that EE affect growth at the level of GH 
sensitivity, IGF synthesis, and IGF sensitivity.  
     As a biological indicator of exposure to EE, vitellogenin mRNA levels were measured (Kime 
et al., 1999). Our results indicate that the tissue cultures were exposed and responsive to EE. The 
ability of EE to modulate growth at the level of the GH-IGF axis was supported by several 
observations. First, E2 and NP were able to decrease steady-state levels of GHR-encoding 
mRNAs in liver; however, all three EE decreased steady-state levels of GHR1 and GHR2 in 
muscle. These effects were not uniform, as EE had no effect on expression of GHR1 or GHR2 
mRNA in gill, which is in agreement with previous findings in our lab (Norbeck et al., 2011). 
Functional expression of GHRs, as assessed by 125I-GH binding, was also significantly depressed 
in liver (following E2 and NP treatment) and muscle (following treatment with all three EE), 
while no effect was observed in gill, which is consistent with the mRNA data obtained. Second, 
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EE were able to suppress IGF-1 and IGF-2 mRNAs in liver and gill in both a time-and 
concentration-dependent manner, with the exception of IGF-2 mRNA abundance in βS-treated 
tissue. Lastly, EE were able to modulate IGFR1A and IGFR1B mRNA expression. These effects 
were most pronounced in IGFR1A for E2- and NP-treated gill and muscle tissue. E2 and NP 
were also able to significantly reduce binding capacity as assessed by 125-I-IGF binding to IGFR. 
Collectively, these data indicate that EE may reduce sensitivity to GH, production of IGFs, and 
sensitivity to IGFs. These effects are not only compound specific, but also tissue- and isoform-
specific. This may be the result of differential expression of receptors (e.g., GHRs, IFGRs) in 
teleosts with either similar or distinct function (Very et al., 2005; Saera-Vila et al., 2007). 
    Our results are in agreement with previous studies that have examined the effects of EE on 
different aspects of growth. For example, in vitro exposure of tilapia and rainbow trout to 17β-
estradiol was shown to decrease expression of IGF-1 and IGF-2 mRNA in hepatocytes (Riley et 
al., 2004; Davis et al., 2008; Norbeck et al., 2011). Similarly, tilapia exposed to 17α-
ethinylestradiol (EE2) had decreased levels of IGF-1 expression in liver (Shved et al., 2008). In 
the study by Shved and colleagues, GH mRNA was also inhibited by treatment with EE2. In vivo 
studies have also demonstrated a decrease in hepatic IGF-1 mRNA levels in fathead minnows 
exposed to E2 (Filby et al., 2006). Additionally, plasma levels of circulating IGF-1 were reduced 
in salmon and tilapia exposed to E2 or nonylphenol (Arsenault et al., 2004; Riley et al., 2004; 
McCormick et al., 2005; Davis et al., 2008), whereas GH plasma levels were either unaffected or 
increased in tilapia and rainbow trout exposed to E2 (Holloway & Leatherland, 1997; Davis et 
al., 2008). In mammals GHR expression appears to be estrogen-regulated in a tissue-dependent 
manner. For example, in rats treatment with estrogen has been shown to decrease brain 
expression of GHR mRNA (Bennet et al., 1996). However, a time- and concentration-dependent 
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increase in GH gene expression was observed in rat pituitary GH3 cells exposed to NP (Dang et 
al., 2009). The expression level differences between tissues and species may result from 
differential expression of the ER subtypes (Leung et al., 2004). Differences in GH and IGF 
mRNA expression may also be due to different stages of sexual maturation (and therefore 
different levels of endogenous estrogens), as both suppression and enhancement of GH-IGF 
elements have been observed in teleosts, particularly in gonadal tissues, depending on state of 
maturation (Gioacchini et al., 2005).   
     The interaction of EE with the GH-IGF system is complex, as multiple isoforms of ligands, 
receptors, and binding proteins exist. It is possible that EE can act not only directly on the GH-
IGF axis (i.e., GH sensitivity, IGF sensitivity) to affect growth, but evidence also shows that 
binding proteins may be affected by EE. For example, Riley et al. (2004) found that two 
isoforms of IGF binding proteins in tilapia were differentially affected following E2 treatment, 
which was sex-dependent. Additionally, studies have shown that EE are capable of affecting 
thyroid hormone (Filby et al., 2006) in fish. As thyroid hormone is known to play a role in 
growth, this may be another avenue by which EE are eliciting effects on the GH-IGF axis. 
     Future studies should focus on elucidating the points of cross-talk between the estrogen (and 
other EE) and growth signaling pathways. Both βS and NP have been shown to be capable of 
binding to the estrogen receptor (Tremblay & Van Der Kraak, 1998) thereby forming an active 
transcription factor capable of binding to genes possessing an estrogen response elements. In 
addition, estrogen has been shown to interact with GHR signaling pathways (JAK-STAT, Erk, 
PI3K/Akt) (Leung et al., 2004). Interference with the JAK-STAT pathway, which plays a critical 
role in IGF-1 expression, and/or the Erk and PI3K/Akt pathways, which are necessary for IGFR 
action, could lend support to the observed effects of EE on organismal growth. 
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CHAPTER 4: ENVIRONMENTAL ESTROGENS MODULATE THE GROWTH 
HORMONE-INSULIN-LIKE GROWTH FACTOR SYSTEM VIA SUPPRESSION OF 
GROWTH-RELATED SIGNALING CASCADES 
Abstract 
 
     Endocrine disrupting compounds (EDCs) generally act by binding to and activating the 
estrogen receptor, thus eliciting estrogen-like effects in an organism. While there is growing 
evidence to support the observation that EDCs possess growth-inhibiting effects, the mechanisms 
by which these physiological effects occur are poorly understood. Further complicating the 
elucidation of these pathways is the apparent ability of estrogen and estrogen-like compounds to 
act in the classical genomic manner, as well as via the activation of nongenomic pathways. In 
this study, we used rainbow trout (Oncorhynchus mykiss) hepatocytes and gill filaments to assess 
the effects of EDCs, specifically environmental estrogens (EE), on growth-related signaling 
pathways in vitro. We examined the effects of 17β-estradiol (E2), β-sitosterol (βS), and 4-n-
nonylphenol (NP) on the JAK-STAT, MAPK, and PI3K-Akt pathways at various concentrations 
(0-150 μg/L) and time points (0-180 min). Environmental estrogen treatment resulted in the 
deactivation of JAK-STAT, MAPK, and PI3K-Akt pathways in a time- and concentration-
dependent manner. Maximum suppression for each pathway was rapid, typically occurring at 10 
to 30 min. The effective concentrations for dephosphorylation of JAK-STAT, MAPK, and PI3K-
Akt were compound- and tissue-dependent. The observed effects appeared to occur via an 
estrogen-dependent pathway, as indicated by treatment with an ER antagonist, ICI 182,780. 
Additionally, co-incubation with a pathway agonist (growth hormone) and EE linked the 
deactivation of these signaling pathways to suppressed growth hormone receptor 1 (GHR1), 
GHR2, insulin-like growth factor-1 (IGF-1), IGF-2, insulin-like growth factor receptor 1A 
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(IGFR1A), and IGFR1B mRNA expression levels. In agreement with the observed results, 
suppressor of cytokine signaling 2 (SOCS-2) mRNA expression was elevated. Collectively, these 
findings suggest biological pathways by which EE may regulate growth-related gene expression.  
Introduction 
     Endocrine disrupting compounds (EDCs) are exogenous compounds found in an assortment 
of common materials such as pesticides, personal care products, plastics, and detergents that alter 
the normal physiology of an organism or its progeny. The increased production, use, and 
disposal of an expanding array of EDCs has led to increased introduction of these compounds 
into the environment, which is of concern because of their well-known detrimental effects (e.g., 
tumorigenesis, reproductive abnormalities, etc.). Environmental estrogens (EE) are a specific 
class of EDCs that include endogenous and synthetic animal estrogens (e.g., 17β-estradiol), 
phytoestrogens (β-sitosterol), mycotoxins (e.g., zearalenone), organochlorine pesticides (e.g., 
DDT), polychlorinated biphenyls (PCBs), and alkylphenol polyethoxylates (APEs; e.g., 4-
nonylphenol) (Turner, 1999).  
     The growth hormone (GH)-insulin-like growth factor-1 (IGF-1) system modulates a number 
of physiological processes such as growth, cellular differentiation, metabolism, reproduction, 
immune function, and behavior (Bjornsson et al., 2004; Duan, 1997; Hull & Harvey, 2000; 
Madsen & Bern, 1993; Mancera & McCormick, 1998; Norrelund, 2005). The GH-IGF system 
primarily regulates growth at the cellular level. Briefly, GH is secreted from the pituitary and 
circulates throughout the organism bound to binding proteins, where it can then bind to its 
receptors (GHRs) primarily on the liver (Butler & LeRoith, 2001; Wood et al., 2005) to activate 
signaling pathways including JAK-STAT, MAPK, and PI3K and subsequently induce the 
synthesis and secretion of IGF-1 (Reindl et al., 2011). Additionally, IGF-1 can be secreted to a 
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lesser extent in tissues such as gill and muscle. IGF, once bound to its receptors (IGFRs) can 
stimulate cellular growth, proliferation, and differentiation in target tissues via activation of 
pathways including MAPK and PI3K. 
     Gonadal steroids, such as estrogen, have been shown to affect somatic growth in vertebrates 
(Leung et al., 2004) by modulating components of the GH-IGF system. For example, studies 
have shown that in vivo treatment with 17β-estradiol can cause an increase in plasma GH in 
rainbow trout and tilapia (Holloway and Leatherland, 1997; Melamed et al., 1995). The interplay 
between estrogen and the GH-IGF system has also been observed at the level of IGF-1 
expression, as 17β-estradiol has been shown to decrease hepatic IGF-1 expression in tilapia, 
salmon, and gilthead sea bream (Davis et al., 2007; Riley et al., 2004; Lerner et al., 2007; 
Carnevali et al., 2005) and IGF-1 serum levels in tilapia and salmon (Davis et al., 2007; Lerner et 
al., 2007). In addition, we previously observed that both in vivo and in vitro treatment with 17β-
estradiol causes a decrease in both GHR and IGFR synthesis and sensitivity, as well as IGF 
synthesis (Hanson et al., in press).  
     While EE are now known to modulate growth at the level of the GH-IGF axis, very little has 
been reported regarding the cellular mechanisms behind these actions. Both β-sitosterol and 4-n-
nonylphenol have been shown to be capable of binding to the estrogen receptor (Tremblay & 
Van der Kraak, 1998) thereby forming an active transcription factor capable of binding to genes 
possessing an estrogen response element. In addition, estrogen has been shown to interact with 
GHR signaling pathways (JAK-STAT, Erk, PI3K/Akt) and proteins such as suppressor of 
cytokine signaling-2 (SOCS-2) (Leung et al., 2004). While steroidal compounds are known to 
work via classic genomic mechanisms, evidence has also emerged indicating that EE can activate 
rapid nongenomic responses in the cell at low levels (Bulayeva and Watson, 2004). This study 
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chose rainbow trout as a model system to examine the mechanistic effects of EE on growth at the 
level of the GH-IGF system because of their well-characterized GH-IGF signaling system and 
their multiple isoforms of hormones as well as receptor subtypes (Reinecke et al., 2005; Klein 
and Sheridan, 2008). Specifically, the aim of the present study was to further elucidate the 
molecular mechanisms of EE (specifically 17β-estradiol, β-sitosterol, and 4-n-nonylphenol) that 
are responsible for the suppression of the GH-IGF system (i.e., GH sensitivity, IGF sensitivity) 
and subsequently, organismal growth. 
Materials and Methods 
Materials 
     17β-estradiol, DMSO, and an ER antagonist (ICI 182, 780) were purchased from Sigma (St. 
Louis, MO, USA), β-sitosterol was purchased from Calbiochem (San Diego, CA), and 4-n-
nonylphenol was purchased from AlfaAesar (Ward Hill, MA). GH was purchased from GroPep, 
Ltd. (Adelaide, Australia). Phospho-specific and total antibodies for MAPK, Akt, Jak2, STAT5, 
horseradish peroxidase-linked anti-rabbit IgG antibody, and cell lysis buffer were obtained from 
Cell Signaling Technology (Beverly, MA, USA). Molecular weight markers were obtained from 
Bio-Rad Laboratories (Hercules, CA, USA). 
Experimental Animals 
     Juvenile rainbow trout of both sexes were obtained from Dakota Trout Ranch near 
Carrington, ND, USA and transported to North Dakota State University. Fish were maintained in 
800-l circular tanks supplied with recirculated (100% replacement volume per day) dechlorinated 
municipal water at 14° C under a 12L:12D photoperiod and were fed to satiation twice daily with 
AquaMax Grower (PMI Nutrition International, Inc., Brentwood, MO), except 24 before 
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experimental manipulations. All procedures were performed in accordance approved by the 
North Dakota State University Institutional Animal Care and Use Committee. 
Experimental Conditions 
     To investigate the signaling pathways disrupted by EE, fish (ca. 30 g) were anesthetized by 
immersion in 0.05% (v/v) 2-phenoxyethanol, measured, weighed and bled via the severed caudal 
vessel. Tissues (gill arches, liver) were removed, perfused ex vivo with 0.75% (w/v) saline 
solution, and stored in ice-cold Hank’s Buffered Salt Solution (in mM: 137 NaCl, 5.4 KCl, 4 
NaHCO3, 1.7 CaCl2, 0.8 MgSO4, 0.5 KH2PO4, 0.3 Na2HPO4, 10 HEPES, and 4 glucose; pH 7.6). 
Livers were cut into 1 mm3 pieces while immersed in Hank’s on ice. Additionally, individual gill 
filaments were dissected from the arches while immersed in Hank’s on ice. All tissues were 
pooled and washed three times with Hank’s Balanced Salt Solution with 0.24% BSA, 2 ml Gibco 
MEM amino acid mix (50x)/100 mL, and 1 mL Gibco nonessential amino acid mix (100x)/100 
mL. Tissues were plated in 24-well culture plates (8-10 liver pieces, 12-15 gill filaments) 
containing 1-mL of Hank’s medium with 0.24% BSA, 2 ml Gibco MEM amino acid mix 
(50x)/100 mL, and 1 mL Gibco nonessential amino acid mix (100x)/100 mL and preincubated at 
14 °C under 100% O2 while being and shaken at 100 rpm in a gyratory shaker. For the first 
experiment, following the 3 h preincubation, media was removed and tissues were subjected to 
either a time-course or a concentration-course of three estrogenic compounds: 17β-estradiol 
(Sigma, St. Louis, MO), β-sitosterol (Calbiochem, San Diego, CA) and 4-n-nonylphenol 
(AlfaAesar, Ward Hill, MA). All compounds were dissolved in ethanol; the final concentration 
of ethanol did not exceed 0.007%. For the dose course the following treatments were 
administered for all tissues: E2 (0.1 µg/l, 1.0 µg/l, 10 µg/l, 100 µg/l), βS (1.0 µg/l, 10 µg/l, 75 
µg/l, 150 µg/l), and NP (1.0 µg/l, 10 µg/l, 75 µg/l, 150 µg/l) for 30 min. A time course of 0 min, 
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5 min, 10 min, 30 min, 60 min, and 180 min was used to examine rapid signaling effects at 
concentrations of 10 µg/l (E2) or 75 µg/l (βS, NP) on gill and liver. Following incubation, tissues 
were immediately placed on dry ice and stored at -80° C for later mRNA and western analyses. 
     For the second experiment, following the 3 h preincubation, media was removed and each of 
the tissues was subjected to treatment with or without an ER antagonist, ICI 182,780 (10-6 M), 
for 2 h. Following the 2 h incubation period, EE (E2, βS, NP) treatment was administered at 
concentrations of 10 μg/L (E2), 75 μg/L (βS), and 75 μg/L (NP). The control group received 
DMSO (Sigma, St. Louis, MO). For mRNA analysis, tissues were collected 6 h after EE 
treatment.  
     For the third experiment, following the 3 h preincubation, media was removed and the 
hepatocytes and gill filaments were co-incubated with a pathway agonist, growth hormone (GH) 
(Reindl et al., 2011), at 100 ng/mL, and EE (E2, βS, NP) at concentrations of 10 μg/L (E2), 75 
μg/L (βS), and 75 μg/L (NP) for 15 min for signaling analysis. Following incubation, tissues 
were immediately placed on dry ice and stored at -80° C for later western analyses.   
Quantitative Real-Time PCR 
     Frozen tissues were homogenized and total RNA was extracted using RNAzol reagent ® 
(Molecular Research Center, Cincinnati, OH) according to the manufacturer’s protocol. RNA 
pellets were dissolved in 75 µL RNase-free deionized water. Total RNA was quantified by UV 
(A260) spectrophotometry and then diluted with RNase-free deionized water to 200 ng/µl. RNA 
was reverse transcribed in a 10-µl reaction using 200 ng total RNA with an AffinityScript QPCR 
cDNA Synthesis Kit (Stratagene, La Jolla, CA) as described by the manufacturer’s protocol. 
     As previously described (Very et al., 2005; Poppinga et al., 2007; Malkuch et al., 2008), 
steady-state mRNA levels of GHR1, GHR2, IGF-1, IGF-2, IGFR1A, and IGFR1B were 
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determined by quantitative real-time PCR using a Stratagene Mx 3000p detection system 
(Stratagene, La Jolla, CA). Real-time PCR reactions were carried out for controls, standards, and 
samples in a 10 µl total volume (5 µl 2X Brilliant Master Mix; 0.5 µl of each gene-specific 
probe, forward primer, and reverse primer at concentrations optimized for each RNA species). 
Cycling parameters were set as follows: 95° C for 10 min, and 50 cycles of 92° C for 15 s plus 
57° C for 1 min. Sample copy number was calculated from the threshold cycle number (CT), and 
the CT was related to a gene-specific standard curve following normalization to β-actin. 
     ABI Primer Express® Version 2 software was used to design SOCS-2-specific 
oligonucleotide primers (forward: 5’-CACACAACGGGACGGTTCA-3’; reverse: 5’-
CCTGGTGGCGTTGTTGATG-3’) for real-time PCR based on known SOCS-2 sequence using 
and subsequently synthesized by Sigma-Genosys (The Woodlands, TX, USA). Steady-state 
mRNA levels of SOCS-2 were determined by quantitative real-time PCR using PerfeCTa 
SYBR® Green SuperMix (Quanta Biosciences, Gaithersburg, MD, USA). Real-time PCR 
reactions were carried out for controls, standards, and sampled in a 10 µl total volume (5 µL 2X 
SYBR Green SuperMix, 0.5 µL mixed primers, 2.5 µL nuclease free water). Cycling parameters 
were set as follows: 95° C for 3 min, 40 cycles of 95° C for 15 s plus 61° C for 45 sec, and 1 
cycle of 95° C for 1 min, 55° C for 30 sec, and 95° C for 30 sec. Sample copy number was 
calculated from the threshold cycle number (CT). Conditions were optimized for the dissociation 
curve indicating primer-dimer formation was absent.  
Western Blotting 
     Activation of signaling pathways in hepatocytes and gill filaments was measured from 
experiment three by homogenizing the tissues with 100 µL 1 x cell lysis buffer (Cell Signaling 
Technology). Lysates were subsequently incubated on ice for 10 min and centrifuged at 16,000 g 
154 
 
 
for 10 min at 4° C. The protein concentration of the supernatant was determined using the 
Bradford protein assay for microplates (Bio-Rad Laboratories). Samples containing 50 µg total 
protein were then separated on a 7.5% SDS-PAGE gel and transferred to a 0.45 µm 
nitrocellulose membrane (Bio-Rad Laboratories). Membranes were blocked with 5% nonfat milk 
in TBS-Tween20 (TBS-T) at room temperature for 1 h. Membranes were washed three times 
with TBS-T and incubated with the indicated rabbit antiserum (1:000) in 5% BSA TBS-T buffer 
overnight (4° C). Membranes were then washed with TBS-T and incubated at room temperature 
with goat-anti-rabbit IgG-HRP antiserum (1:2000) for 1 h, washed, and visualized using ECL 
detection system (GE Healthcare, Buckinghamshire, UK) and bands were quantified with a 
FluorChem FC2 imager (Alpha Innotech). Membranes were stripped under reducing conditions 
(100 mM β-mercaptoethanol, 2% SDS, 62.5 mM Tris-HCl, pH 6.7 for 30 min at 50° C with 
agitation), washed twice with a large volume of TBS-T, and the immunodetection protocol was 
repeated with the control antiserums. Antibodies were validated as previously described (Reindl 
et al., 2011). 
Statistics  
     Quantitative data are expressed as means ± S.E.M. Statistical differences were analyzed by 
ANOVA followed by Duncan’s multiple range test using SigmaStat (SPSS, Chicago, IL). A 
probability of 0.05 was used to indicate significance. 
Results 
 
EE Selectively Deactivate/Activate Signaling Pathways 
 
     The deactivation of biological signaling pathways by EE was studied in hepatocytes and gill 
filament lysates from fish tissues treated in vitro probed with phospho-specific and control 
antibodies. Phospho-JAK2, phosopho-STAT5, phospho-Akt, and phospho-Erk were all detected 
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in the treated hepatocytes and gill filaments. Environmental estrogens deactivated JAK2, 
STAT5, Akt, and MAPK in a concentration- and time-related manner (Fig. 26, Fig. 27, Fig. 28, 
Fig. 29). Maximum suppression of JAK2 and STAT5 was rapid and occurred within 10 min (Fig. 
26, Fig. 28). Deactivation of Akt, a downstream target of PI3K, and Erk was less rapid, with the 
lowest degree of phosphorylation observed at 30 min and with suppressive effects persisting 
through 180 min (Fig. 27, Fig. 29). Progressively lower degrees of phosphorylation were 
observed following treatment with the concentration course (Fig. 26, Fig. 27, Fig. 28, Fig. 29). 
The observed effects were both compound- and tissue-dependent. Phosphorylation of JAK2 and 
STAT5 was significantly suppressed at concentrations as low as 10 μg/L (E2) and 1 μg/L (NP) in 
hepatocytes (Fig. 26). β-sitosterol, however, did not have significant concentration effects. 
Marginally more robust effects were observed in JAK2 and STAT5 phosphorylation levels in gill 
filaments, where phosphorylation was significantly inhibited at levels as low as 0.1 μg/L (E2) 
and 1 μg/L (NP) (Fig. 28). Akt and Erk similarly had reduced phosphorylation states in liver 
tissue, where values decreased to 61% (E2), 82% (βS), and 53% (NP) of control values for Akt, 
and 67% (E2), 78% (βS), and 63% (NP) of control values for Erk (Fig. 27). In gill filaments, 
treatment with E2, βS, and NP produced Akt phosphorylation states that were 64%, 87%, and 
61%, of control values, respectively (Fig. 29). Similar results were observed for Erk 
phosphorylation where values were depressed to 65% (E2), 87% (βS), and 63% (NP) of control 
values at the highest treatment concentrations. 
ER-Dependence and Linkage of Cell Signaling Elements to EE-inhibited Growth Components 
     The involvement of the JAK-STAT, PI3K-Akt, and MAPK pathways appeared to be ER 
dependent, as indicated by the co-incubation of EE and ICI 182,780 in liver and gill filaments. In  
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Figure 26. Effects of environmental estrogens (EE) on the abundance of phosphorylated JAK2 
and STAT5 in hepatocytes. (A and C) Time-dependent phosphorylation of JAK2 and STAT5 
respectively in cells incubated with 10 μg/L 17β-estradiol (E2), 75 μg/L β-sitosterol (βS), or 75 
μg/L nonylphenol (NP). (B and D) Concentration-dependent phosphorylation of JAK2 and 
STAT5 respectively in cells incubated in the presence of E2, βS, or NP for 30 min (control is 0 
μg/L EE). Cell lysates were separated by SDS-PAGE followed by western immunoblotting and 
quantified with a FluorChem imager. The abundance of phosphorylated JAK2 and STAT5 was 
normalized to total JAK2 and STAT5. Data are presented as means ± SEM (n=4). Means with 
different letters are significantly different (p < 0.05). 
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Figure 27. Effects of environmental estrogens (EE) on the abundance of phosphorylated Akt and 
Erk in hepatocytes. (A and C) Time-dependent phosphorylation of Akt and Erk respectively in 
cells incubated with 10 μg/L 17β-estradiol (E2), 75 μg/L β-sitosterol (βS), or 75 μg/L 
nonylphenol (NP). (B and D) Concentration-dependent phosphorylation of Akt and Erk 
respectively in cells incubated in the presence of E2, βS, or NP for 30 min (control is 0 μg/L EE). 
Cell lysates were separated by SDS-PAGE followed by western immunoblotting and quantified 
with a FluorChem imager. The abundance of phosphorylated Akt and Erk was normalized to 
total Akt and Erk. Data are presented as means ± SEM (n=4). Means with different letters are 
significantly different (p < 0.05). 
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Figure 28. Effects of environmental estrogens (EE) on the abundance of phosphorylated JAK2 
and STAT5 in gill filaments. (A and C) Time-dependent phosphorylation of JAK2 and STAT5 
respectively in cells incubated with 10 μg/L 17β-estradiol (E2), 75 μg/L β-sitosterol (βS), or 75 
μg/L nonylphenol (NP). (B and D) Concentration-dependent phosphorylation of JAK2 and 
STAT5 respectively in cells incubated in the presence of E2, βS, or NP for 30 min (control is 0 
μg/L EE). Cell lysates were separated by SDS-PAGE followed by western immunoblotting and 
quantified with a FluorChem imager. The abundance of phosphorylated JAK2 and STAT5 was 
normalized to total JAK2 and STAT5. Mean are presented as means ± SEM (n=4). Means with 
different letters are significantly different (p < 0.05). 
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Figure 29. Effects of environmental estrogens (EE) on the abundance of phosphorylated Akt and 
Erk in gill filaments. (A and C) Time-dependent phosphorylation of Akt and Erk respectively in 
cells incubated with 10 μg/L 17β-estradiol (E2), 75 μg/L β-sitosterol (βS), or 75 μg/L 
nonylphenol (NP). (B and D) Concentration-dependent phosphorylation of Akt and Erk 
respectively in cells incubated in the presence of E2, βS, or NP for 30 min (control is 0 μg/L EE). 
Cell lysates were separated by SDS-PAGE followed by western immunoblotting and quantified 
with a FluorChem imager. The abundance of phosphorylated JAK2 and STAT5 was normalized 
to total Akt and Erk. Data are presented as means ± SEM (n=4). Means with different letters are 
significantly different (p < 0.05). 
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hepatocytes, steady-state mRNA expression of GHR1 and GHR2 was suppressed in all of the 
EE-treated groups. The effects were most pronounced following E2 and NP treatment. Co- 
incubation with ICI 182,780, led to an increase in expression of both GHR1 and GHR2 to near 
control levels (Fig. 30). Similarly, IGFs were significantly suppressed to levels that were 69% 
(E2), 76 % (βS), and 71% (NP) of control values for IGF-1 and 71% (E2), 78 % (βS), and 75% 
(NP) of control values for IGF-2 when treated with EE alone. Treatment with ICI 182,780 
restored IGF-1 mRNA expression to 98%, 102%, and 101% of control values following E2, βS, 
and NP treatment, respectively. Similarly, in the ICI 182,780-treated cells, IGF-2 steady-state 
mRNA expression levels increased to values that were 94% (E2), 104% (βS), and 97% (NP) of 
control values (Fig.30). SOCS-2 mRNA expression was additionally examined in liver where 
values increased to 124%, 108%, and 116% of control values following treatment of hepatocytes 
with E2, βS, and NP, respectively (Fig. 32). 
     In gill, the most pronounced effects were observed on IGF and IGFR mRNA expression (Fig. 
31), where treatment with E2, βS, and NP significantly suppressed IGF and IGFR mRNA levels, 
an effect that could be reversed via treatment with ICI 182,780 co-incubation. Significant effects 
on GHR expression were observed only for E2-treated gill filaments, where levels decreased to 
82% of the control value, and could be rescued to 98% of control values by ICI 182,780 
treatment (Fig. 31). In gill, SOCS-2 mRNA expression increased following EE treatment to 
levels that were up to 168% (E2) of control values. Co-incubation with ICI 182,780 lead to a 
suppression of SOCS-2 mRNA expression to levels near control values (109% in E2-treated 
groups) (Fig. 32). 
     We examined the linkage of specific cell signaling pathways to EE-inhibited GH, IGF, and 
IGFR expression in hepatocytes and gill filaments. Following stimulation with a known pathway 
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Figure 30. Effects of environmental estrogens (EE) and an estrogen receptor antagonist, ICI 
182,780 on the abundance of (A) growth hormone receptors (GHRs) and (B) insulin-like growth 
factors (IGFs) in hepatocytes. Tissues were incubated for 2 h in the presence or absence of ICI 
182,780, followed by 6 h with 10 μg/L 17β-estradiol (E2), 75 μg/L β-sitosterol (βS), or 75 μg/L 
nonylphenol (NP). Data are presented as mean ± SEM (n=6). For a given gene subtype, means 
with different letters are significantly different (p < 0.05) different from each other. 
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Figure 31. Effects of environmental estrogens (EE) and an estrogen receptor antagonist, ICI 
182,780, on the abundance of (A) growth hormone receptors (GHRs), (B) insulin-like growth 
factors (IGFs), and (C) insulin-like growth factor receptors (IGFRs) in gill filaments. Tissues 
were incubated for 2 h in the presence or absence of ICI 182,780, followed by 6 h with 10 μg/L 
17β-estradiol (E2), 75 μg/L β-sitosterol (βS), or 75 μg/L nonylphenol (NP). Data are presented as 
mean ± SEM (n=6). For a given gene subtype, means with different letters are significantly 
different (p < 0.05) different from each other. 
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Figure 32. Effects of environmental estrogens (EE) and an estrogen receptor antagonist, ICI 
182,780 on the abundance of suppressor of cytokine signaling 2 (SOCS-2) expression in (A) 
hepatocytes and (B) gill filaments. Tissues were incubated for 2 h in the presence or absence of 
ICI 182,780, followed by 6 h with 10 μg/L 17β-estradiol (E2), 75 μg/L β-sitosterol (βS), or 75 
μg/L nonylphenol (NP). Data are presented as mean ± SEM (n=6). For a given gene subtype, 
means with different letters are significantly different (p < 0.05) different from each other. 
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Figure 33. Blockade of GH-stimulated activation by environmental estrogens (EE). Effects on 
the phosphorylation of (A) JAK2, (B) STAT5, (C) Akt, and (D) Erk in hepatocytes incubated 
with 10 μg/L 17β-estradiol (E2), 75 μg/L β-sitosterol (βS), or 75 μg/L nonylphenol (NP) for 15 
min following GH stimulation. Cell lysates were separated by SDS-PAGE followed by western 
immunoblotting and quantified with a FluorChem imager. The abundance of phosphorylated 
JAK2, STAT5, Akt, and Erk was normalized to total JAK2, STAT5, Akt, and Erk, respectively. 
Data are presented as mean ± SEM (n=4). Means with different letters are significantly different 
(p < 0.05). 
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Figure 34. Blockade of GH-stimulated activation by environmental estrogens (EE).  Effects on 
the phosphorylation of (A) JAK2, (B) STAT5, (C) Akt, and (D) Erk in gill filaments incubated 
with 10 μg/L 17β-estradiol (E2), 75 μg/L β-sitosterol (βS), or 75 μg/L nonylphenol (NP) for 15 
min following GH stimulation. Cell lysates were separated by SDS-PAGE followed by western 
immunoblotting and quantified with a FluorChem imager. The abundance of phosphorylated 
JAK2, STAT5, Akt, and Erk was normalized to total JAK2, STAT5, Akt, and Erk, respectively. 
Data are presented as mean ± SEM (n=4). Means with different letters are significantly different 
(p < 0.05). 
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agonist (GH) phosphorylation states of JAK-STAT, PI3K-Akt, and Erk were increased as  
expected. Following treatment with EE, there was a significant suppression in GH-stimulated 
pathway activation for JAK2, STAT5, Akt, and Erk in hepatocytes (Fig. 33). Similarly, GH-
stimulated phosphorylation of the JAK2, STAT5, Akt, and Erk pathways in gill filaments was 
significantly blocked following treatment with E2, βS, and NP. 
Discussion 
     Environmental estrogens can bind to the estrogen receptor in mammals and teleosts, albeit 
with a much lower affinity than estrogen (Bonefeld-Jorgensen et al., 2001; Tremblay and Van 
der Kraak, 1998; Knudsen and Pottinger, 1999; Sumpter and Jobling, 1993). While EDCs can 
bind to the ER, the elucidation of signaling mechanisms has been complicated by a host of 
factors including multiple ER subtypes (ERα, ERβ in mammals; ERα1, ERα2, ERβ1, ERβ2 in 
rainbow trout), tissue-specific distribution of the receptors, and the ability of estrogen to produce 
both genomic and nongenomic responses in the cell.       
     The results of the present study confirm the inhibitory effects of EE on GH sensitivity, IGF 
synthesis, and IGF sensitivity and support our initial hypothesis that the JAK-STAT, MAPK, and 
PI3K-Akt pathways in part regulate the inhibition of GHR mRNAs, IGF mRNAs, and IGFR 
mRNAs in EE-treated hepatocytes and gill filaments of rainbow trout (Fig. 35). These findings 
help to establish mechanisms through which EE exert growth suppressing actions.  
     GH and IGF signaling involve the activation of signaling cascades, including JAK-STAT, 
ERK, and PI3K/Akt. Environmental estrogens inhibited the phosphorylation of ERK 1/2, Akt, 
JAK, and STAT in hepatocytes and gill filaments in a time-and concentration-dependent manner. 
These effects were ER-dependent, as treatment with each of the compounds and the ER 
antagonist, ICI 182,780, reestablished mRNA expression levels that were similar to those 
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observed in control tissues. Additionally, treatment with EE blocked GH-induced pathway 
activation of JAK-STAT, Erk, and PI3K/Akt in hepatocytes and gill filaments, thus linking these 
cell signaling elements to the previously observed suppression of GHR, IGF, and IGFR mRNA 
expression.      
     Environmental estrogens have been shown to have a variety of effects on signaling 
mechanisms in cells and the interplay of EEs and growth signaling pathways is complex. Our 
study demonstrated that JAK2, STAT5, Akt, and Erk represent targets for rapid, nongenomic 
responses to EEs in rainbow trout hepatocytes and gill filaments. This is in agreement with what 
others have found in ovariectomized hypophysectomized rats, where JAK-STAT activation was 
inhibited by E2 in a dose-dependent manner (Murphy and Friesen, 1988). Our results were also 
in agreement with a study in mussel hemocytes that found that NP and bispenol A (BPA) 
significantly decreased the phosphorylation state of STAT5 (Canesi et al., 2004). However, 
several studies have found contradictory results to those observed in our study. For example, NP, 
coumestrol, endosulfan, dichlorodiphenyldichloroethylene (DDE), and dieldrin were shown to 
stimulate a rapid membrane-initiated cascade in a prolactinoma cell line via a membrane bound 
ER (Bulayeva and Watson, 2004). Similarly, BPA, octylphenol, NP, and E2 rapidly (within 30 
minutes) activated ERK1/2 and PI3K signaling cascades in rat pituitary cells (Dang et al., 2009). 
Dichlorodiphenyltrichloroethane (DDT) and polychlorinated biphenyls (PCBs) were also shown 
to be capable of activating the receptor tyrosine kinase pathways such as JAK-STAT (Enan et 
al., 1998; Shen and Novak, 1997). 
     The majority of studies in vertebrates have been in mammalian cell lines, not teleosts, thus 
representing one possible avenue for the observed differences in activation/deactivation of 
signaling pathways. There are four ER isoforms in rainbow trout (Nagler et al., 2007), whereas 
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in mammals only two isoforms exist. Teleost and tetrapod ER amino acid homology is as low as 
32% for the A/B domain and 36% for the E domain (Socorro et al., 2000), and thus may have 
differential physiological functions. These ERs are differentially expressed and may exhibit 
different binding affinities for EE, thus activating or repressing different signaling pathways. 
Moreover, it is plausible that there are specific ER subtype-effector pathway linkages responsible 
for the contrasting effects. While results (time and concentration, activation and inhibition) may 
be variable, it is evident that EDCs can disrupt signaling pathways to affect physiological 
endpoints such as cellular growth and proliferation.  
     One possible mechanism by which EE reduce pathway activation may be through regulation 
of SOCS proteins. In our study, EE were shown to increase SOCS-2 mRNA expression in an 
ER-dependent fashion, an effect that was in agreement with what has previously been observed 
following exposure to endogenous estradiol (Tollet-Egnell et al., 1999; Paul et al., 2000; Leong 
et al., 2004; Rico-Bautista et al., 2004). As E2 is able to up-regulate SOCS-2 mRNA expression, 
it is reasonable to suggest that EEs are capable of eliciting the same results on SOCS-2.  
     In the context of growth-related signaling cascades, E2 can stimulate SOCS-2 expression and 
thus inhibit GH signaling via the JAK-STAT pathway, specifically JAK2 (Jelinsky et al., 2003; 
Leung et al., 2003; Leung et al., 2004). SOCS-2 may also play a role in IGF-1 signaling, as 
SOCS-2 has been shown to bind to IGFRs (Dey et al., 1998). Through the inhibition of JAK2 or 
IGF-1 signaling elements, SOCS-2 regulation may influence multiple effector pathways 
downstream of the GHR and IGFR. In mammals, there are eight SOCS family members, 
SOCS1-7 and cytokine-inducible SH2-containing protein (CISH). In rainbow trout, there are 7 
known SOCS genes (Wang et al., 2010), however less is known about how SOCS functions in 
teleosts. It is possible that isoforms other than SOCS-2 may be contributing to the observed 
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Figure 35. Schematic diagram of environmental estrogens (17β-estradiol, β-sitosterol, and 4-n-
nonyphenol) signaling mechanisms in juvenile rainbow trout hepatocytes and gill filaments. 
Estradiol, E2; heat shock protein 90, Hsp90; estrogen receptor, ER; phosphorylated, P; 
transcription factor, TF; estrogen response element, ERE; growth hormone, GH; insulin-like 
growth factor, IGF. 
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effects on the regulation of growth-related signaling. For example, in a murine hepatoma cell 
line, SOCS-1 and SOCS-6 were shown to inhibit insulin receptor tyrosine kinase activity and the 
insulin-dependent activation of ERK1/2 and Akt kinase (Mooney et al., 2001).  
     The dependence of growth-related gene expression (i.e., depressed GHR, IGF, and IGFR 
mRNA expression) on the ER in hepatocytes and gill filaments was in agreement with what 
others have observed. Dang et al. (2009) found that pituitary cells treated with NP, BPA, or E2 
exhibited increased GH mRNA and protein expression, an effect that could be blocked by co-
incubation with an ER antagonist (ICI 182,780). Thus, whether EE are stimulatory or inhibitory 
on GH-IGF system components, the ER appears to be an obligatory component in signal 
transmission.  
     We have linked the EE-related suppression in GHR, IGF, and IGFR mRNA expression to 
pathways known to be involved in growth processes. Cross-talk with the GH-IGF system may be 
explained by multiple observations. First, from a genomic perspective, transcription factors such 
as AhR, Sp1, Sp3, MSY-1, C/EBP, and various STATs may be involved in the interplay of EE 
and growth signaling (Schwartzbauer and Menon 1998; Wang & Jiang 2005; Wood et al., 2005; 
Schwartzbauer et al., 1998; Yu et al., 1999; Elango et al., 2006). For example, IGFR expression 
has been shown to be capable of activation via AP-1 and Sp1 (Fujimoto et al., 2004; Sarfstein et 
al., 2006), two transcription factors known to interact with ER. 
     Second, direct interaction of the ER with signaling pathways has been evidenced by the co-
immunoprecipitation of ERα with different components of the MAPK pathway in MCF-7 cells, 
thus indicating direct action on Ras/Erk kinases (Migliaccio, et al., 1996). Similarly, E2 bound to 
ERα has been observed to induce the phosphorylation of the IGFR in human embryonic kidney 
cells and thus alter Erk1/2 signaling (Kahlert et al., 2000). In endothelial cells, E2 treatment ERα 
172 
 
 
has been shown to bind the p85α regulatory subunit of PI3K, thus activating the PI3K/Akt 
signaling cascades (Simoncini et al., 2000; Hisamoto et al., 2001). Furthermore, IGF-1 can 
phosphorylate ERα, thus activating the receptor and allowing the ER complex to elicit its 
physiological effects (Lanzino et al., 2008). In mammalian cell lines, cross-talk has been 
observed between estrogen receptors, IGF, and IGFR (Kahlert et al., 2000; Klotz et al., 2002; 
Mendez et al., 2006), thus eliciting downstream signaling effects and regulating the expression of 
proteins involved in IGF-1 signal transduction (Bernard et al., 2006). Further evidence 
supporting the cross-talk between EDCs and growth pathways was provided by Yu et al. (2012), 
as E2 was able to rapidly stimulate MAPK signaling and induced the phosphorylation of ERα in 
cells with a functional IGFR versus in those without. Collectively, there are several points of 
interaction that exist between E2 and GH-IGF signaling and it appears as though bidirectional 
cross-talk may be responsible for our observed results. Furthermore, cross-talk between 
pathways such as MAPK, PI3K/Akt, and JAK-STAT has been observed. Previously, our lab 
found that JAK2 is critical for GHR signal propagation through ERK or PI3K/Akt in trout 
hepatocytes. This was evidenced via the complete inhibition of ERK and Akt activation when 
hepatocytes were treated with a JAK2 inhibitor (1,2,3,4,5,6-hexabromocyclohexane) (Reindl et 
al., 2011). In the context of growth hormone signaling, it is reasonable to suggest that the effects 
of EE on ERK and PI3K phosphorylation may simply be due to the downstream nature of these 
kinases in relation to JAK.  
     Complicating the elucidation of the cross-talk between these pathways is that many of these 
studies have investigated effects of EDCs using immortal cancer cell lines, which undergo 
growth and proliferation at an accelerated rate and thus may not accurately portray EE action on 
natural somatic growth. Additional problems arise in generalizing the response(s) of cells to 
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EDCs, as many of these response(s) appear to follow a non-traditional dose-response curve 
(Watson et al., 2007) and seem to be both tissue- and compound-dependent.  
     We have demonstrated for the first time the inhibition of signaling pathways by EE. There is a 
dearth of information regarding the negative regulation of JAK-STAT, PI3K-Akt, and MAPK by 
EDCs, thus future studies should focus on further elucidating the mechanisms (i.e., alternative 
pathways, transcription factors, epigenetic alterations) by which these compounds are inhibiting 
growth.  
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GENERAL CONCLUSIONS 
 
     Endocrine disrupting compounds are a diverse group of chemical compounds that have been 
shown to have deleterious effects on a host of physiological processes, including reproduction, 
osmoregulation, and growth (Hester and Harrison, 1999; Kime et al., 1998; Madsen et al., 2004, 
McCormick et al., 2005; Lerner et al., 2007). Our work focused primarily on the effects of 
EDCs, specifically EE, on growth. We have shown that 17β-estradiol, β-sitosterol, and 4-n-
nonylphenol directly modulate overall organismal growth and growth at the molecular level 
through inhibitory actions on GH sensitivity, IGF synthesis, and IGF sensitivity (Fig. 35). In 
addition to EE affecting the GH-IGF system in terms of growth at the organismal and molecular 
level, the components of this system were affected in terms of osmoregulatory ability as well. 
The effects in our studies appeared to be tissue- and compound-dependent.   
     In terms of osmoregulatory ability, aqueous EE exposure was associated with elevated plasma 
chloride levels and suppressed GHR1, GHR2, IGF-1, IGF-2, IGFR1A, and IGFR1B mRNA 
expression following aqueous exposure to E2, βS, and NP in tissues including liver, gill, white 
muscle, and red muscle over the course of the salt water challenge. E2, βS, and NP abolished or 
attenuated normal salinity-induced changes in the expression of GHR, IGF, and IGFR1 mRNAs, 
indicating that EE reduce salinity adaptation by inhibiting components of the GH-IGF system. 
     Environmental estrogen treatment in vivo significantly reduced food conversion, body 
condition (i.e., condition factor), HSI, and body growth. Environmental estrogen-inhibited 
growth resulted from alterations in peripheral elements of the GH-IGF system. In vivo and in 
vitro, E2, βS, and NP reduced the expression of GHR, IGF, and IGFR mRNA and protein; 
however, the effects varied in an EE-, compound- and tissue-specific manner. The findings of 
our in vivo study were the most pronounced in terms of effects on the GH-IGF system and 
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Figure 36. Schematic representation of the growth hormone-insulin-like growth factor system in 
vertebrates and known negatively regulated targets (growth hormone sensitivity, insulin-like 
growth factor synthesis, insulin-like growth factor sensitivity) of endocrine disrupting 
compounds. growth hormone, GH; growth hormone binding protein, GHBP; growth hormone 
receptor, GHR; insulin-like growth factor, IGF; insulin-like growth factor binding protein; 
insulin-like growth factor receptor, IGFBP; endocrine disrupting compounds, EDCs. 
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indicate that EE disrupt post-embryonic growth by reducing GH sensitivity, IGF production, and 
IGF sensitivity. 
     E2, βS, and NP treatment resulted in the deactivation of JAK-STAT, MAPK, and PI3K-Akt 
pathways in a time- and concentration-dependent manner. Maximum suppression for each 
pathway was rapid, typically occurring at 10 to 30 min. The effective concentrations for 
dephosphorylation of JAK-STAT, MAPK, and PI3K-Akt were compound- and tissue-dependent, 
with the most pronounced effects being observed in hepatocytes. The observed effects appeared 
to occur via an estrogen-dependent pathway and the deactivation of these pathways was linked to 
suppressed GHR, IGF, and IGFR mRNA expression levels. The findings suggest biological 
mechanisms by which EE may regulate growth-related gene expression.  
     Based upon the collective results of this dissertation, EE appear to directly modulate the 
mRNA expression and functional expression of GHRs, and the expression of IGF mRNA in the 
liver. Although transcriptional effects were observed in gill and muscle, the effects of all three 
EE appeared to be most pronounced on IGF mRNA expression in the liver. This may indicate the 
primary mechanism by which EE are inhibiting growth. The evidence suggests that EE affect the 
GH-IGF system at the level of the liver and at the level of target tissues; however, it is possible 
that the effects on the target tissues are downstream effects occurring from the actions of EE on 
the liver. Additionally, the possibility remains that the changes in mRNA expression of IGFs are 
not transduced into changes in plasma protein levels of IGF in vitro or in vivo. The same 
possibility should be considered when examining IGF and IGFR functional expression in vivo.  
     Endocrine disrupting chemicals are thought to elicit their physiological effects primarily via  
 
nuclear receptors. Elucidating the multifaceted effects of EDCs has proved to be difficult for a 
host of reasons, including the ability of estrogen to signal via genomic and nongenomic  
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mechanisms, the numerous ER subtypes and the tissue-specific distribution of these subtypes,  
and the varying milieu of proteins in tissues (Matthews and Gustafsson, 2003; Nagler et al., 
2007; Routledge et al., 2000). Effective concentrations of EDCs are largely variable and chronic 
versus acute exposure may bring about diverse physiological actions. In addition to the 
differentially expressed receptors, the receptors may be linked to different effector pathways, and 
ultimately result in different physiological endpoints. For example, in metabolic processes (e.g., 
glucose and lipid metabolism), ERα has been linked to anti-lipogenesis and glucose tolerance, 
while ERβ has been linked to impaired glucose and lipid homeostasis (Faulds et al., 2012). 
     Furthermore, variable effects between this study and studies by others may arise from 
differences in length of exposure, age and health of the organism, and type of exposure (i.e., 
aqueous versus dietary). The effects of EE on organismal growth could be attributed to the 
exposure of rainbow trout during the juvenile life stage, a stage in which the fish are typically 
undergoing rapid growth (Mommsen, 2001). From a life history perspective, juveniles typically 
allocate energy resources towards growth prior to undergoing sexual maturation. Treatment at 
this critical life stage with a sex steroid such as estrogen, or a compound mimicking estrogen 
(e.g., β-sitosterol, nonlyphenol), may reprogram the fish to divert energy resources towards 
reproduction rather than growth. By decreasing the growth rate of these organisms, and thus 
perhaps maturation rates, the lifetime fitness of an organism may be altered. 
Future Studies 
     The data here focused only on the primary source of IGFs, the liver, and a few target tissues 
(i.e., gill and muscle). As the control of growth is initiated in the brain, effects of EE on other 
endocrine organs such as the hypothalamus and pituitary should be examined to determine the 
primary site of action for EE. It is possible that the observed results were merely downstream 
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effects of negative regulation at the level of the hypothalamus and pituitary by EE. Another 
aspect of growth regulation that should be examined is the effects of EE on GHBP and IGFBP, 
as these two proteins are responsible for the bioavailability of GH and IGF (Baumann et al, 
1988; Edens and Talamantes, 1998). Previous studies in mammals have indicated that co-
incubation with E2 and GH increased GHBP mRNA and GHBP protein levels (Carmignac et al., 
1993; Contreras and Talamantes, 1999). Similarly, E2 stimualted the release of IGFBPs (25 kDa 
and 30 kDa) from hepatocytes in tilapia (Riley et al, 2004) and IGFBP-1 in humans (Paassilta et 
al., 2000), thus it is reasonable to suggest that EE may in part exert their physiological effects on 
growth through binding proteins. In addition to looking at binding proteins, it is possible that 
estrogen and EE may exert effects on IGF-3 expression. Ethinylestradiol negatively affected 
IGF-3 mRNA expression in a sex-dependent manner in the gonads of tilapia (Berishvili et al., 
2010). While IGF-3 appears to be gonad-specific, the effects of EE on this form of IGF may 
assist in understanding the overall picture of the effects of EE on growth at all levels. Effects on 
transcription factors such as Sp1, Sp3, and MSY-1 should also be considered in future studies 
examining EE action on growth processes, as these transcription factors have been shown to 
regulate GHR promoter activity and GHR synthesis (Schwartzbauer et al., 1998; Yu et al., 1999).  
     The influence of EE on other hormonal systems involved in growth including reproduction, 
thyroid hormones, and metabolism, should additionally be further examined in order to 
determine the interplay between and among these systems. As exposure to combinations of 
EDCs may dramatically affect cellular function (mixtures may be 1000 times more potent than 
singularly acting EDCs (Arnold et al., 1996; Benachour et al., 2007; Kortenkamp, 2008), 
expanded research should focus on the possible synergistic actions of these compounds. Lastly, 
future studies should examine other signaling mechanisms and transcription factors that may be 
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altered by EE, as well as any epigenetic modifications to the genes responsible for somatic 
growth. 
Summary 
     Our understanding of the complex mechanisms by which EE modulate growth at the 
organismal and molecular level is still rudimentary. The multitude of physiological processes 
that are negatively affected by EE are indicative of the consequences associated with a world that 
is undergoing rapid technological development. While it is unfortunate that the adverse effects of 
compounds such as DES and DDT did not come to light sooner, with adequate research and 
understanding, a ban was implemented on these harmful compounds. Interestingly, the ban on 
DDT is thought to be one of the primary reasons that the bald eagle population has recovered 
after being on the brink of extinction (Stokstad, 2007).  Avoiding hazard in the design of new 
chemicals (“green chemistry”) may be one beneficial practice to the reduction of exposure to 
EDCs. Programs such as the Tiered Protocol for Endocine Disruption (TiPED) promote green 
chemistry and help identify a chemical’s endocrine disrupting effects early in the design process 
via in silico, cell-specific, and whole organismal-based assays. Programs such as TiPED may be 
extremely beneficial to organismal health; unfortunately, it is not possible to detect every EDC 
as the understanding of these compounds and their effects on physiology is still advancing 
(Schug et al., 2013). Ultimately, this work will inform policies and practices aimed at reducing 
the impact of EE on our environment and on wildlife and human health.  
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